ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
HPD	4-hydroxyphenylpyruvate dioxygenase(HPD)	Homo sapiens				GO:0006559~L-phenylalanine catabolic process,GO:0006572~tyrosine catabolic process,GO:0055114~oxidation-reduction process,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003868~4-hydroxyphenylpyruvate dioxygenase activity,GO:0046872~metal ion binding,	IPR004360:Glyoxalase/fosfomycin resistance/dioxygenase domain,IPR005956:4-hydroxyphenylpyruvate dioxygenase,	hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis,hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,hsa01100:Metabolic pathways,	140350~Hawkinsinuria,276710~Tyrosinemia, type III,	PIRSF009283:4-hydroxyphenylpyruvate dioxygenase,		3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Dioxygenase,Disease mutation,Iron,Mental retardation,Metal-binding,Oxidoreductase,Phenylalanine catabolism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tyrosine catabolism,	chain:4-hydroxyphenylpyruvate dioxygenase,helix,metal ion-binding site:Iron,modified residue,sequence conflict,sequence variant,strand,turn,
ADAM7	ADAM metallopeptidase domain 7(ADAM7)	Homo sapiens				GO:0006508~proteolysis,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,	IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR018358:Disintegrin, conserved site,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 7,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ALX1	ALX homeobox 1(ALX1)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001502~cartilage condensation,GO:0001755~neural crest cell migration,GO:0001843~neural tube closure,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009952~anterior/posterior pattern specification,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0030326~embryonic limb morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048704~embryonic skeletal system morphogenesis,GO:0060021~palate development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005794~Golgi apparatus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		613456~Frontonasal dysplasia 3,		SM00389:HOX,	Acetylation,Activator,Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:ALX homeobox protein 1,DNA-binding region:Homeobox,modified residue,sequence conflict,short sequence motif:OAR,
ABCA13	ATP binding cassette subfamily A member 13(ABCA13)	Homo sapiens				GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 13,domain:ABC transporter 1,domain:ABC transporter 2,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
ATP6V0A4	ATPase H+ transporting V0 subunit a4(ATP6V0A4)	Homo sapiens				GO:0001503~ossification,GO:0006885~regulation of pH,GO:0007035~vacuolar acidification,GO:0007588~excretion,GO:0007605~sensory perception of sound,GO:0008286~insulin receptor signaling pathway,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,GO:0090383~phagosome acidification,	GO:0000220~vacuolar proton-transporting V-type ATPase, V0 domain,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0031526~brush border membrane,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0051117~ATPase binding,	IPR002490:ATPase, V0 complex, subunit 116kDa,IPR026028:ATPase, V0 complex, subunit 116kDa, eukaryotic,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05323:Rheumatoid arthritis,	602722~Renal tubular acidosis, distal, autosomal recessive,	PIRSF001293:V-type proton ATPase 116 kda subunit a isoform 1,		Cell membrane,Coiled coil,Complete proteome,Disease mutation,Hydrogen ion transport,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:V-type proton ATPase 116 kDa subunit a isoform 4,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ATP6V0D2	ATPase H+ transporting V0 subunit d2(ATP6V0D2)	Homo sapiens				GO:0007034~vacuolar transport,GO:0007035~vacuolar acidification,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016324~apical plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0030670~phagocytic vesicle membrane,GO:0033179~proton-transporting V-type ATPase, V0 domain,GO:0033181~plasma membrane proton-transporting V-type ATPase complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR002843:ATPase, V0 complex,  c/d subunit,IPR016727:ATPase, V0 complex, subunit d,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04142:Lysosome,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05152:Tuberculosis,hsa05203:Viral carcinogenesis,hsa05323:Rheumatoid arthritis,		PIRSF018497:V-type ATPase, subunit d,		Complete proteome,Hydrogen ion transport,Ion transport,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit d 2,sequence variant,
ATP6V1B1	ATPase H+ transporting V1 subunit B1(ATP6V1B1)	Homo sapiens				GO:0001503~ossification,GO:0006885~regulation of pH,GO:0007588~excretion,GO:0007605~sensory perception of sound,GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016241~regulation of macroautophagy,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0042472~inner ear morphogenesis,GO:0045851~pH reduction,GO:0046034~ATP metabolic process,GO:0055074~calcium ion homeostasis,GO:0090383~phagosome acidification,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005902~microvillus,GO:0012505~endomembrane system,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0005524~ATP binding,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0032403~protein complex binding,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005723:ATPase, V1 complex, subunit B,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR022879:V-type ATP synthase regulatory subunit B/beta,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,	267300~Renal tubular acidosis with deafness,			Complete proteome,Deafness,Disease mutation,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit B, kidney isoform,mutagenesis site,sequence conflict,sequence variant,short sequence motif:PDZ-binding,
ATP6V1C2	ATPase H+ transporting V1 subunit C2(ATP6V1C2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0030177~positive regulation of Wnt signaling pathway,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0046983~protein dimerization activity,	IPR004907:ATPase, V1 complex, subunit C,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Alternative splicing,Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit C 2,sequence variant,splice variant,
BARX1	BARX homeobox 1(BARX1)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0009888~tissue development,GO:0009952~anterior/posterior pattern specification,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030855~epithelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048513~animal organ development,GO:0048536~spleen development,GO:0055123~digestive system development,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000047:Helix-turn-helix motif,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Homeobox,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein BarH-like 1,compositionally biased region:Poly-Ala,DNA-binding region:Homeobox,helix,sequence conflict,sequence variant,splice variant,
BRINP3	BMP/retinoic acid inducible neural specific 3(BRINP3)	Homo sapiens				GO:0007050~cell cycle arrest,GO:0045666~positive regulation of neuron differentiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0071300~cellular response to retinoic acid,	GO:0005576~extracellular region,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0030425~dendrite,GO:0043025~neuronal cell body,		IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR020864:Membrane attack complex component/perforin (MACPF) domain,				SM00457:MACPF,	Alternative splicing,Cell cycle,Complete proteome,Glycoprotein,Growth arrest,Mitochondrion,Reference proteome,Secreted,Signal,	chain:Protein FAM5C,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
CCL7	C-C motif chemokine ligand 7(CCL7)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0010332~response to gamma radiation,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071361~cellular response to ethanol,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,GO:0031727~CCR2 chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Inflammatory response,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,strand,turn,
CLMP	CXADR like membrane protein(CLMP)	Homo sapiens				GO:0048565~digestive tract development,	GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,		615237~Congenital short bowel syndrome,		SM00406:IGv,SM00408:IGc2,SM00409:IG,	Cell junction,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Tight junction,Transmembrane,Transmembrane helix,	chain:Adipocyte adhesion molecule,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DDX43	DEAD-box helicase 43(DDX43)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,	GO:0005622~intracellular,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00322:KH,SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Polymorphism,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX43,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:KH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
DIRAS1	DIRAS family GTPase 1(DIRAS1)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043406~positive regulation of MAP kinase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0051019~mitogen-activated protein kinase binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR020849:Small GTPase superfamily, Ras type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Proteomics identification,Reference proteome,	chain:GTP-binding protein Di-Ras1,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,strand,turn,
DNTT	DNA nucleotidylexotransferase(DNTT)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0033198~response to ATP,GO:0071897~DNA biosynthetic process,	GO:0000790~nuclear chromatin,GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003912~DNA nucleotidylexotransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001726:DNA nucleotidylexotransferase (TdT) / DNA-directed DNA/RNA polymerase mu,IPR002054:DNA-directed DNA polymerase X,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027292:DNA nucleotidylexotransferase (TdT),IPR027421:DNA polymerase family X lyase domain,	hsa03450:Non-homologous end-joining,hsa04640:Hematopoietic cell lineage,		PIRSF000817:DNA nucleotidyltransferase,PIRSF501175:DNA nucleotidylexotransferase [Parent=PIRSF000817],	SM00292:BRCT,SM00483:POLXc,	3D-structure,Alternative splicing,Complete proteome,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Terminal addition,Transferase,	chain:DNA nucleotidylexotransferase,domain:BRCT,helix,metal ion-binding site:Magnesium,metal ion-binding site:Sodium; via carbonyl oxygen,region of interest:Involved in ssDNA binding,region of interest:Mediates interaction with DNTTIP2,sequence conflict,sequence variant,splice variant,strand,turn,
DNAJC12	DnaJ heat shock protein family (Hsp40) member C12(DNAJC12)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,				IPR001623:DnaJ domain,				SM00271:DnaJ,	3D-structure,Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 12,domain:J,helix,sequence variant,splice variant,turn,
ELF5	E74 like ETS transcription factor 5(ELF5)	Homo sapiens				GO:0001712~ectodermal cell fate commitment,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0035019~somatic stem cell population maintenance,GO:0045596~negative regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060644~mammary gland epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa04917:Prolactin signaling pathway,			SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:ETS-related transcription factor Elf-5,DNA-binding region:ETS,domain:PNT,helix,sequence conflict,splice variant,strand,turn,
EHF	ETS homologous factor(EHF)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0030855~epithelial cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050673~epithelial cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,				SM00251:SAM_PNT,SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ETS homologous factor,DNA-binding region:ETS,domain:PNT,modified residue,sequence conflict,sequence variant,splice variant,
FRG2C	FSHD region gene 2 family member C(FRG2C)	Homo sapiens					GO:0005634~nucleus,		IPR026245:Protein FRG2,					Complete proteome,Nucleus,Polymorphism,Reference proteome,	chain:Protein FRG2-like-2,sequence variant,
FXYD4	FXYD domain containing ion transport regulator 4(FXYD4)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:1903779~regulation of cardiac conduction,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005267~potassium channel activity,GO:0017080~sodium channel regulator activity,GO:0051117~ATPase binding,	IPR000272:Ion-transport regulator, FXYD motif,	hsa04960:Aldosterone-regulated sodium reabsorption,				Complete proteome,Ion channel,Ion transport,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:FXYD domain-containing ion transport regulator 4,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
HEPACAM2	HEPACAM family member 2(HEPACAM2)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0051297~centrosome organization,GO:0051301~cell division,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005819~spindle,GO:0016021~integral component of membrane,GO:0030496~midbody,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	ADP-ribosylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Disulfide bond,Glycoprotein,Golgi apparatus,Immunoglobulin domain,Membrane,Mitosis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:HEPACAM family member 2,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
L1CAM	L1 cell adhesion molecule(L1CAM)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0045773~positive regulation of axon extension,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0044295~axonal growth cone,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules (CAMs),	303350~CRASH syndrome,303350~MASA syndrome,304100~Corpus callosum, partial agenesis of,307000~Hydrocephalus due to aqueductal stenosis,307000~Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,307000~Hydrocephalus with Hirschsprung disease,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hereditary spastic paraplegia,Hirschsprung disease,Immunoglobulin domain,Membrane,Mental retardation,Neurodegeneration,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule L1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LYPD8	LY6/PLAUR domain containing 8(LYPD8)	Homo sapiens				GO:0050829~defense response to Gram-negative bacterium,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,		IPR016054:Ly-6 antigen / uPA receptor -like,					Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein UNQ511/PRO1026,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,signal peptide,
MAGEL2	MAGE family member L2(MAGEL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0034314~Arp2/3 complex-mediated actin nucleation,GO:0042147~retrograde transport, endosome to Golgi,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051127~positive regulation of actin nucleation,GO:0070534~protein K63-linked ubiquitination,	GO:0005634~nucleus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0030904~retromer complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,	IPR002190:MAGE protein,		615547~Schaaf-Yang syndrome,		SM01373:SM01373,	Autism spectrum disorder,Biological rhythms,Complete proteome,Cytoplasm,Endosome,Mental retardation,Nucleus,Obesity,Reference proteome,Repressor,Transcription,Transcription regulation,Transport,Ubl conjugation pathway,	chain:MAGE-like protein 2,domain:MAGE,
MTRNR2L1	MT-RNR2-like 1(MTRNR2L1)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,							Complete proteome,Cytoplasm,Reference proteome,Secreted,
MTRNR2L10	MT-RNR2-like 10(MTRNR2L10)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,							Complete proteome,Cytoplasm,Reference proteome,Secreted,
NAT8L	N-acetyltransferase 8 like(NAT8L)	Homo sapiens					GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016021~integral component of membrane,GO:0030867~rough endoplasmic reticulum membrane,GO:0031966~mitochondrial membrane,	GO:0008080~N-acetyltransferase activity,GO:0017188~aspartate N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa01100:Metabolic pathways,	614063~N-acetylaspartate deficiency,			Acyltransferase,Complete proteome,Cytoplasm,Endoplasmic reticulum,Membrane,Microsome,Mitochondrion,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:N-acetyltransferase 8-like protein,compositionally biased region:Pro-rich,domain:N-acetyltransferase,transmembrane region,
NKAIN4	Na+/K+ transporting ATPase interacting 4(NKAIN4)	Homo sapiens				GO:0002028~regulation of sodium ion transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR008516:Na,K-Atpase Interacting protein,					Cell membrane,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4,sequence variant,transmembrane region,
POU3F4	POU class 3 homeobox 4(POU3F4)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007605~sensory perception of sound,GO:0021879~forebrain neuron differentiation,GO:0090103~cochlea morphogenesis,GO:2001054~negative regulation of mesenchymal cell apoptotic process,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003680~AT DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000327:POU-specific,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR016362:Transcription factor, homeobox/POU,IPR017970:Homeobox, conserved site,		304400~Deafness, X-linked 2,	PIRSF002629:POU domain class 3 transcription factor, brain type,	SM00352:POU,SM00389:HOX,	Complete proteome,Deafness,Disease mutation,DNA-binding,Homeobox,Non-syndromic deafness,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:POU domain, class 3, transcription factor 4,DNA-binding region:Homeobox,domain:POU-specific,sequence conflict,sequence variant,
RAB3B	RAB3B, member RAS oncogene family(RAB3B)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0017157~regulation of exocytosis,GO:0018125~peptidyl-cysteine methylation,GO:0019882~antigen processing and presentation,GO:0051586~positive regulation of dopamine uptake involved in synaptic transmission,GO:0097494~regulation of vesicle size,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0030141~secretory granule,GO:0031982~vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0030742~GTP-dependent protein binding,GO:0031489~myosin V binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					3D-structure,Cell membrane,Complete proteome,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Phosphoprotein,Prenylation,Protein transport,Reference proteome,Transport,	chain:Ras-related protein Rab-3B,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
RANBP3L	RAN binding protein 3 like(RANBP3L)	Homo sapiens				GO:0046827~positive regulation of protein export from nucleus,GO:0046907~intracellular transport,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0008536~Ran GTPase binding,GO:0070412~R-SMAD binding,	IPR000156:Ran binding domain,IPR011993:Pleckstrin homology-like domain,				SM00160:RanBD,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Ran-binding protein 3-like,domain:RanBD1,sequence variant,splice variant,
ROS1	ROS proto-oncogene 1, receptor tyrosine kinase(ROS1)	Homo sapiens				GO:0002066~columnar/cuboidal epithelial cell development,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0010629~negative regulation of gene expression,GO:0010966~regulation of phosphate transport,GO:0016049~cell growth,GO:0023014~signal transduction by protein phosphorylation,GO:0030154~cell differentiation,GO:0032006~regulation of TOR signaling,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0070372~regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,	IPR000033:LDLR class B repeat,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR003961:Fibronectin, type III,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,				SM00060:FN3,SM00135:LY,SM00219:TyrKc,	3D-structure,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase ROS,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,site:Breakpoint for translocation to form GOPC-ROS1 fusion protein,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
RHBG	Rh family B glycoprotein (gene/pseudogene)(RHBG)	Homo sapiens				GO:0015695~organic cation transport,GO:0015696~ammonium transport,GO:0019740~nitrogen utilization,GO:0070634~transepithelial ammonium transport,GO:0072488~ammonium transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014731~spectrin-associated cytoskeleton,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0046658~anchored component of plasma membrane,	GO:0008519~ammonium transmembrane transporter activity,GO:0030506~ankyrin binding,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,					Alternative splicing,Ammonia transport,Cell membrane,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Ammonium transporter Rh type B,glycosylation site:N-linked (GlcNAc...),mutagenesis site,region of interest:Interaction with ANK3,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
RHCG	Rh family C glycoprotein(RHCG)	Homo sapiens				GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0015695~organic cation transport,GO:0015696~ammonium transport,GO:0015837~amine transport,GO:0019740~nitrogen utilization,GO:0030855~epithelial cell differentiation,GO:0042592~homeostatic process,GO:0070634~transepithelial ammonium transport,GO:0072488~ammonium transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0008519~ammonium transmembrane transporter activity,GO:0030506~ankyrin binding,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,					3D-structure,Ammonia transport,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Ammonium transporter Rh type C,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
RHAG	Rh-associated glycoprotein(RHAG)	Homo sapiens				GO:0006873~cellular ion homeostasis,GO:0015670~carbon dioxide transport,GO:0015672~monovalent inorganic cation transport,GO:0015695~organic cation transport,GO:0015696~ammonium transport,GO:0015701~bicarbonate transport,GO:0019740~nitrogen utilization,GO:0035378~carbon dioxide transmembrane transport,GO:0048821~erythrocyte development,GO:0060586~multicellular organismal iron ion homeostasis,GO:0072488~ammonium transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008519~ammonium transmembrane transporter activity,GO:0022840~leak channel activity,GO:0030506~ankyrin binding,GO:0035379~carbon dioxide transmembrane transporter activity,	IPR001905:Ammonium transporter,IPR002229:Blood group Rhesus C/E/D polypeptide,IPR024041:Ammonium transporter AmtB-like domain,		185000~Overhydrated hereditary stomatocytosis,268150~Anemia, hemolytic, Rh-null, regulator type,Rh-mod syndrome~Rh-mod syndrome,			Alternative splicing,Ammonia transport,Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,Hereditary hemolytic anemia,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Ammonium transporter Rh type A,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
UGT1A8	UDP glucuronosyltransferase family 1 member A8(UGT1A8)	Homo sapiens				GO:0006631~fatty acid metabolic process,GO:0008152~metabolic process,GO:0008202~steroid metabolic process,GO:0009804~coumarin metabolic process,GO:0017144~drug metabolic process,GO:0042573~retinoic acid metabolic process,GO:0043086~negative regulation of catalytic activity,GO:0045922~negative regulation of fatty acid metabolic process,GO:0045939~negative regulation of steroid metabolic process,GO:0051552~flavone metabolic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,GO:0052697~xenobiotic glucuronidation,GO:1904224~negative regulation of glucuronosyltransferase activity,GO:2001030~negative regulation of cellular glucuronidation,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0004857~enzyme inhibitor activity,GO:0005496~steroid binding,GO:0005504~fatty acid binding,GO:0008144~drug binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 1-1,chain:UDP-glucuronosyltransferase 1-10,chain:UDP-glucuronosyltransferase 1-3,chain:UDP-glucuronosyltransferase 1-4,chain:UDP-glucuronosyltransferase 1-5,chain:UDP-glucuronosyltransferase 1-6,chain:UDP-glucuronosyltransferase 1-7,chain:UDP-glucuronosyltransferase 1-8,chain:UDP-glucuronosyltransferase 1-9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,transmembrane region,
UGT2A1	UDP glucuronosyltransferase family 2 member A1 complex locus(UGT2A1)	Homo sapiens				GO:0007608~sensory perception of smell,GO:0008152~metabolic process,GO:0009593~detection of chemical stimulus,GO:0009813~flavonoid biosynthetic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Membrane,Olfaction,Polymorphism,Reference proteome,Sensory transduction,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 2A1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
UGT2B4	UDP glucuronosyltransferase family 2 member B4(UGT2B4)	Homo sapiens				GO:0006711~estrogen catabolic process,GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:0009813~flavonoid biosynthetic process,GO:0052695~cellular glucuronidation,GO:0052696~flavonoid glucuronidation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001972~retinoic acid binding,GO:0015020~glucuronosyltransferase activity,GO:0016758~transferase activity, transferring hexosyl groups,	IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase,	hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,				Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Membrane,Microsome,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-glucuronosyltransferase 2B4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,transmembrane region,
B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6(B3GNT6)	Homo sapiens				GO:0006486~protein glycosylation,GO:0009101~glycoprotein biosynthetic process,GO:0016266~O-glycan processing,GO:0016269~O-glycan processing, core 3,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047223~beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,GO:0047224~acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,				Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 6,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
VSTM2L	V-set and transmembrane domain containing 2 like(VSTM2L)	Homo sapiens				GO:0043524~negative regulation of neuron apoptotic process,	GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Reference proteome,Signal,	chain:V-set and transmembrane domain-containing protein 2-like protein,disulfide bond,domain:Ig-like,sequence conflict,signal peptide,splice variant,
VTCN1	V-set domain containing T cell activation inhibitor 1(VTCN1)	Homo sapiens				GO:0001562~response to protozoan,GO:0002250~adaptive immune response,GO:0042102~positive regulation of T cell proliferation,GO:0050868~negative regulation of T cell activation,GO:0072602~interleukin-4 secretion,GO:0072643~interferon-gamma secretion,GO:1900042~positive regulation of interleukin-2 secretion,	GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0005102~receptor binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00409:IG,	3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Lipoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set domain-containing T-cell activation inhibitor 1,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
WFDC12	WAP four-disulfide core domain 12(WFDC12)	Homo sapiens				GO:0010951~negative regulation of endopeptidase activity,GO:0042742~defense response to bacterium,	GO:0005576~extracellular region,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR008197:Whey acidic protein-type  4-disulphide core,				SM00217:WAP,	Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Protease inhibitor,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:WAP four-disulfide core domain protein 12,disulfide bond,domain:WAP,signal peptide,
WT1-AS	WT1 antisense RNA(WT1-AS)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Wilms tumor-associated protein,sequence conflict,sequence variant,
WT1	Wilms tumor 1(WT1)	Homo sapiens		h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,	General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0003156~regulation of organ formation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007281~germ cell development,GO:0007356~thorax and anterior abdomen determination,GO:0007507~heart development,GO:0007530~sex determination,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009888~tissue development,GO:0017148~negative regulation of translation,GO:0030308~negative regulation of cell growth,GO:0030325~adrenal gland development,GO:0030539~male genitalia development,GO:0030855~epithelial cell differentiation,GO:0032835~glomerulus development,GO:0032836~glomerular basement membrane development,GO:0035802~adrenal cortex formation,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060231~mesenchymal to epithelial transition,GO:0060421~positive regulation of heart growth,GO:0060539~diaphragm development,GO:0060923~cardiac muscle cell fate commitment,GO:0061032~visceral serous pericardium development,GO:0071320~cellular response to cAMP,GO:0071371~cellular response to gonadotropin stimulus,GO:0072075~metanephric mesenchyme development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072166~posterior mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072302~negative regulation of metanephric glomerular mesangial cell proliferation,GO:2000020~positive regulation of male gonad development,GO:2000195~negative regulation of female gonad development,GO:2001076~positive regulation of metanephric ureteric bud development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000976:Wilm's tumour protein, N-terminal,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017987:Wilm's tumour protein,	hsa05202:Transcriptional misregulation in cancer,	136680~Frasier syndrome,156240~Mesothelioma, somatic,194070~Wilms tumor, type 1,194080~Denys-Drash syndrome,256370~Nephrotic syndrome, type 4,608978~Meacham syndrome,		SM00355:ZnF_C2H2,	3D-structure,Alternative initiation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA editing,RNA-binding,Signal,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,Zinc-finger,	chain:Wilms tumor protein,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,mutagenesis site,region of interest:Important for interaction with target DNA,sequence conflict,sequence variant,short sequence motif:KTS motif,site:Important for interaction with target DNA,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
ACPP	acid phosphatase, prostate(ACPP)	Homo sapiens				GO:0006144~purine nucleobase metabolic process,GO:0006772~thiamine metabolic process,GO:0009117~nucleotide metabolic process,GO:0016311~dephosphorylation,GO:0046085~adenosine metabolic process,GO:0051930~regulation of sensory perception of pain,GO:0060168~positive regulation of adenosine receptor signaling pathway,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0012506~vesicle membrane,GO:0016021~integral component of membrane,GO:0030175~filopodium,GO:0070062~extracellular exosome,	GO:0003993~acid phosphatase activity,GO:0008253~5'-nucleotidase activity,GO:0016791~phosphatase activity,GO:0042131~thiamine phosphate phosphatase activity,GO:0042802~identical protein binding,GO:0052642~lysophosphatidic acid phosphatase activity,	IPR000560:Histidine phosphatase superfamily, clade-2,					3D-structure,Alternative splicing,Amyloid,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Nucleophile,active site:Proton donor,chain:Prostatic acid phosphatase,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
ADGRF1	adhesion G protein-coupled receptor F1(ADGRF1)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000082:SEA domain,IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR008078:GPCR, family 2, Ig-hepta receptor,IPR017981:GPCR, family 2-like,				SM00303:GPS,	Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 110,domain:GPS,domain:SEA,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADH1C	alcohol dehydrogenase 1C (class I), gamma polypeptide(ADH1C)	Homo sapiens			Energy production and conversion,	GO:0006069~ethanol oxidation,	GO:0005829~cytosol,	GO:0004022~alcohol dehydrogenase (NAD) activity,GO:0004024~alcohol dehydrogenase activity, zinc-dependent,GO:0004745~retinol dehydrogenase activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,	IPR002085:Alcohol dehydrogenase superfamily, zinc-type,IPR002328:Alcohol dehydrogenase, zinc-type, conserved site,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013154:Alcohol dehydrogenase GroES-like,IPR016040:NAD(P)-binding domain,IPR020843:Polyketide synthase, enoylreductase,	hsa00010:Glycolysis / Gluconeogenesis,hsa00071:Fatty acid degradation,hsa00350:Tyrosine metabolism,hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	103780~Alcohol dependence, protection against,168600~Parkinson disease, susceptibility to,		SM00829:SM00829,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Metal-binding,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,	binding site:NAD,chain:Alcohol dehydrogenase 1A,chain:Alcohol dehydrogenase 1B,chain:Alcohol dehydrogenase 1C,helix,metal ion-binding site:Zinc 1; catalytic,metal ion-binding site:Zinc 2,modified residue,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
ALDH1A2	aldehyde dehydrogenase 1 family member A2(ALDH1A2)	Homo sapiens				GO:0001568~blood vessel development,GO:0001822~kidney development,GO:0001889~liver development,GO:0001936~regulation of endothelial cell proliferation,GO:0002138~retinoic acid biosynthetic process,GO:0003007~heart morphogenesis,GO:0006776~vitamin A metabolic process,GO:0007494~midgut development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009855~determination of bilateral symmetry,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0010628~positive regulation of gene expression,GO:0014032~neural crest cell development,GO:0016331~morphogenesis of embryonic epithelium,GO:0021915~neural tube development,GO:0021983~pituitary gland development,GO:0030182~neuron differentiation,GO:0030324~lung development,GO:0030902~hindbrain development,GO:0031016~pancreas development,GO:0031076~embryonic camera-type eye development,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0034097~response to cytokine,GO:0035115~embryonic forelimb morphogenesis,GO:0035799~ureter maturation,GO:0042572~retinol metabolic process,GO:0042573~retinoic acid metabolic process,GO:0042574~retinal metabolic process,GO:0042904~9-cis-retinoic acid biosynthetic process,GO:0043065~positive regulation of apoptotic process,GO:0048384~retinoic acid receptor signaling pathway,GO:0048566~embryonic digestive tract development,GO:0048738~cardiac muscle tissue development,GO:0055114~oxidation-reduction process,GO:0060324~face development,GO:0071300~cellular response to retinoic acid,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,	GO:0001758~retinal dehydrogenase activity,GO:0004028~3-chloroallyl aldehyde dehydrogenase activity,GO:0004029~aldehyde dehydrogenase (NAD) activity,GO:0016491~oxidoreductase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0016918~retinal binding,	IPR015590:Aldehyde dehydrogenase domain,IPR016160:Aldehyde dehydrogenase, conserved site,IPR016161:Aldehyde/histidinol dehydrogenase,IPR016162:Aldehyde dehydrogenase, N-terminal,IPR016163:Aldehyde dehydrogenase, C-terminal,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,NAD,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton acceptor,chain:Retinal dehydrogenase 2,modified residue,nucleotide phosphate-binding region:NAD,sequence variant,site:Transition state stabilizer,splice variant,
AKR1B10	aldo-keto reductase family 1 member B10(AKR1B10)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0006081~cellular aldehyde metabolic process,GO:0007586~digestion,GO:0008202~steroid metabolic process,GO:0016488~farnesol catabolic process,GO:0044597~daunorubicin metabolic process,GO:0044598~doxorubicin metabolic process,GO:0055114~oxidation-reduction process,	GO:0005764~lysosome,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0001758~retinal dehydrogenase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0005515~protein binding,GO:0045550~geranylgeranyl reductase activity,GO:0047718~indanol dehydrogenase activity,	IPR001395:Aldo/keto reductase,IPR018170:Aldo/keto reductase, conserved site,IPR020471:Aldo/keto reductase subgroup,IPR023210:NADP-dependent oxidoreductase domain,	hsa00040:Pentose and glucuronate interconversions,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,		PIRSF000097:aldo-keto reductase,		3D-structure,Acetylation,Complete proteome,Lysosome,NADP,Oxidoreductase,Polymorphism,Reference proteome,Secreted,	active site:Proton donor,binding site:NADP,binding site:Substrate,chain:Aldo-keto reductase family 1 member B10,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Lowers pKa of active site Tyr,strand,turn,
ANGPTL8	angiopoietin like 8(ANGPTL8)	Homo sapiens				GO:0010954~positive regulation of protein processing,GO:0019216~regulation of lipid metabolic process,GO:0044255~cellular lipid metabolic process,GO:0044342~type B pancreatic cell proliferation,GO:0045444~fat cell differentiation,GO:0048469~cell maturation,GO:0050746~regulation of lipoprotein metabolic process,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,	GO:0005179~hormone activity,GO:0005515~protein binding,	IPR026614:Hepatocellular carcinoma-associated protein TD26,					Complete proteome,Diabetes mellitus,Hormone,Lipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Hepatocellular carcinoma-associated protein TD26,sequence variant,signal peptide,
ASB5	ankyrin repeat and SOCS box containing 5(ASB5)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0016021~integral component of membrane,		IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 5,domain:SOCS box,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,
ANKRD2	ankyrin repeat domain 2(ANKRD2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001817~regulation of cytokine production,GO:0006936~muscle contraction,GO:0007517~muscle organ development,GO:0010832~negative regulation of myotube differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045662~negative regulation of myoblast differentiation,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:2000291~regulation of myoblast proliferation,	GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005829~cytosol,GO:0016605~PML body,GO:0030017~sarcomere,GO:0031674~I band,GO:0043231~intracellular membrane-bounded organelle,	GO:0003682~chromatin binding,GO:0008307~structural constituent of muscle,GO:0031432~titin binding,GO:0043422~protein kinase B binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 2,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,splice variant,
APOH	apolipoprotein H(APOH)	Homo sapiens				GO:0001937~negative regulation of endothelial cell proliferation,GO:0002576~platelet degranulation,GO:0006641~triglyceride metabolic process,GO:0007597~blood coagulation, intrinsic pathway,GO:0010596~negative regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030194~positive regulation of blood coagulation,GO:0030195~negative regulation of blood coagulation,GO:0031639~plasminogen activation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0034197~triglyceride transport,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0051917~regulation of fibrinolysis,GO:0051918~negative regulation of fibrinolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0031012~extracellular matrix,GO:0031089~platelet dense granule lumen,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008201~heparin binding,GO:0008289~lipid binding,GO:0042802~identical protein binding,GO:0060230~lipoprotein lipase activator activity,	IPR000436:Sushi/SCR/CCP,IPR015104:Beta-2-glycoprotein-1 fifth domain,				SM00032:CCP,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Beta-2-glycoprotein 1,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,region of interest:Sushi-like,sequence conflict,sequence variant,signal peptide,strand,turn,
AQP6	aquaporin 6(AQP6)	Homo sapiens				GO:0006810~transport,GO:0006833~water transport,GO:0007588~excretion,GO:0009992~cellular water homeostasis,GO:0015706~nitrate transport,GO:0015793~glycerol transport,GO:0042476~odontogenesis,GO:0098656~anion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030658~transport vesicle membrane,	GO:0005215~transporter activity,GO:0005253~anion channel activity,GO:0015112~nitrate transmembrane transporter activity,GO:0015250~water channel activity,GO:0015254~glycerol channel activity,	IPR000425:Major intrinsic protein,IPR022357:Major intrinsic protein, conserved site,IPR023254:Aquaporin 6,IPR023271:Aquaporin-like,					3D-structure,Complete proteome,Cytoplasmic vesicle,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Aquaporin-6,helix,sequence conflict,sequence variant,short sequence motif:NPA 1,short sequence motif:NPA 2,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
AVPR2	arginine vasopressin receptor 2(AVPR2)	Homo sapiens				GO:0001992~regulation of systemic arterial blood pressure by vasopressin,GO:0003084~positive regulation of systemic arterial blood pressure,GO:0003091~renal water homeostasis,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007588~excretion,GO:0007599~hemostasis,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0021537~telencephalon development,GO:0031398~positive regulation of protein ubiquitination,GO:0032609~interferon-gamma production,GO:0032870~cellular response to hormone stimulus,GO:0034097~response to cytokine,GO:0035811~negative regulation of urine volume,GO:0035814~negative regulation of renal sodium excretion,GO:0045907~positive regulation of vasoconstriction,GO:1901652~response to peptide,	GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005000~vasopressin receptor activity,GO:0005515~protein binding,GO:0042277~peptide binding,	IPR000161:Vasopressin V2 receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001817:Vasopressin receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04962:Vasopressin-regulated water reabsorption,	300539~Nephrogenic syndrome of inappropriate antidiuresis,304800~Diabetes insipidus, nephrogenic,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Diabetes insipidus,Disease mutation,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Vasopressin V2 receptor,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ARX	aristaless related homeobox(ARX)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007411~axon guidance,GO:0010628~positive regulation of gene expression,GO:0021759~globus pallidus development,GO:0021800~cerebral cortex tangential migration,GO:0021831~embryonic olfactory bulb interneuron precursor migration,GO:0021846~cell proliferation in forebrain,GO:0021853~cerebral cortex GABAergic interneuron migration,GO:0042127~regulation of cell proliferation,GO:0044241~lipid digestion,GO:0046622~positive regulation of organ growth,GO:0072148~epithelial cell fate commitment,	GO:0005634~nucleus,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001206~transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003682~chromatin binding,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		300004~Proud syndrome,300215~Hydranencephaly with abnormal genitalia,300215~Lissencephaly, X-linked 2,300419~Mental retardation, X-linked 29 and others,308350~Epileptic encephalopathy, early infantile, 1,309510~Partington syndrome,		SM00389:HOX,	Complete proteome,Developmental protein,Differentiation,Disease mutation,DNA-binding,Epilepsy,Homeobox,Lissencephaly,Mental retardation,Neurogenesis,Nucleus,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:Homeobox protein ARX,compositionally biased region:Ala-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,DNA-binding region:Homeobox,sequence variant,short sequence motif:OAR,
ARSI	arylsulfatase family member I(ARSI)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006687~glycosphingolipid metabolic process,GO:0008152~metabolic process,GO:0043687~post-translational protein modification,	GO:0005576~extracellular region,GO:0005788~endoplasmic reticulum lumen,	GO:0004065~arylsulfatase activity,GO:0005515~protein binding,GO:0008484~sulfuric ester hydrolase activity,GO:0046872~metal ion binding,	IPR000917:Sulfatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024607:Sulfatase, conserved site,					Alternative splicing,Calcium,Complete proteome,Endoplasmic reticulum,Glycoprotein,Hydrolase,Metal-binding,Oxidation,Reference proteome,Secreted,Signal,	binding site:Substrate,chain:Arylsulfatase I,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via 3-oxoalanine,modified residue,mutagenesis site,sequence conflict,signal peptide,splice variant,
ASTN1	astrotactin 1(ASTN1)	Homo sapiens				GO:0001764~neuron migration,GO:0007158~neuron cell-cell adhesion,GO:0007626~locomotory behavior,	GO:0005768~endosome,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030136~clathrin-coated vesicle,GO:0043204~perikaryon,		IPR000742:Epidermal growth factor-like domain,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR020864:Membrane attack complex component/perforin (MACPF) domain,IPR026995:Astrotactin,				SM00181:EGF,SM00457:MACPF,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Cytoplasmic vesicle,Disulfide bond,EGF-like domain,Endosome,Glycoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Astrotactin-1,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Fibronectin type-III 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,transmembrane region,
BNC1	basonuclin 1(BNC1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0008284~positive regulation of cell proliferation,GO:0008544~epidermis development,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,Cytoplasm,Differentiation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Signal,Spermatogenesis,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein basonuclin-1,compositionally biased region:Ser-rich,modified residue,mutagenesis site,region of interest:Hydrophobic,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
B3GALT5	beta-1,3-galactosyltransferase 5(B3GALT5)	Homo sapiens				GO:0006486~protein glycosylation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa00603:Glycosphingolipid biosynthesis - globo series,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,3-galactosyltransferase 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
B4GALNT4	beta-1,4-N-acetyl-galactosaminyltransferase 4(B4GALNT4)	Homo sapiens					GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0008376~acetylgalactosaminyltransferase activity,GO:0033842~N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,	IPR008428:Chondroitin N-acetylgalactosaminyltransferase,IPR011658:PA14,				SM00758:PA14,	Complete proteome,Glycoprotein,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
CDH10	cadherin 10(CDH10)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,				SM00112:CA,	Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-10,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDH17	cadherin 17(CDH17)	Homo sapiens				GO:0002314~germinal center B cell differentiation,GO:0002315~marginal zone B cell differentiation,GO:0006810~transport,GO:0006857~oligopeptide transport,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007229~integrin-mediated signaling pathway,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0033626~positive regulation of integrin activation by cell surface receptor linked signal transduction,GO:0034332~adherens junction organization,GO:0035672~oligopeptide transmembrane transport,GO:0048536~spleen development,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0005178~integrin binding,GO:0005215~transporter activity,GO:0005427~proton-dependent oligopeptide secondary active transmembrane transporter activity,GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Glycoprotein,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Cadherin-17,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDH19	cadherin 19(CDH19)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Membrane,Metal-binding,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-19,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CLSTN2	calsyntenin 2(CLSTN2)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0050806~positive regulation of synaptic transmission,GO:0051965~positive regulation of synapse assembly,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0045211~postsynaptic membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR026914:Calsyntenin,				SM00112:CA,	Calcium,Cell adhesion,Cell membrane,Complete proteome,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Calsyntenin-2,compositionally biased region:Glu-rich (highly acidic),domain:Cadherin 1,domain:Cadherin 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CA1	carbonic anhydrase 1(CA1)	Homo sapiens				GO:0006730~one-carbon metabolic process,GO:0015701~bicarbonate transport,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0004064~arylesterase activity,GO:0004089~carbonate dehydratase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016836~hydro-lyase activity,	IPR001148:Alpha carbonic anhydrase,IPR018338:Carbonic anhydrase, alpha-class, conserved site,IPR018442:Carbonic anhydrase, CA-I,IPR023561:Carbonic anhydrase, alpha-class,	hsa00910:Nitrogen metabolism,			SM01057:SM01057,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Lyase,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Zinc,	chain:Carbonic anhydrase 1,helix,metal ion-binding site:Zinc; catalytic,modified residue,sequence conflict,sequence variant,strand,turn,
CES5A	carboxylesterase 5A(CES5A)	Homo sapiens			Lipid metabolism,		GO:0005615~extracellular space,GO:0016021~integral component of membrane,	GO:0016787~hydrolase activity,GO:0052689~carboxylic ester hydrolase activity,	IPR002018:Carboxylesterase, type B,IPR019819:Carboxylesterase type B, conserved site,IPR019826:Carboxylesterase type B, active site,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Serine esterase,Signal,Transmembrane,Transmembrane helix,	active site:Acyl-ester intermediate,active site:Charge relay system,chain:Carboxylesterase 7,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
CPN2	carboxypeptidase N subunit 2(CPN2)	Homo sapiens				GO:0050790~regulation of catalytic activity,GO:0050821~protein stabilization,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0030234~enzyme regulator activity,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00013:LRRNT,SM00082:LRRCT,SM00369:LRR_TYP,	Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Carboxypeptidase N subunit 2,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,
CADM3	cell adhesion molecule 3(CADM3)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0008104~protein localization,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003585:Neurexin/syndecan/glycophorin C,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00294:4.1m,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cell adhesion molecule 3,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CHL1	cell adhesion molecule L1 like(CHL1)	Homo sapiens				GO:0001764~neuron migration,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0008344~adult locomotory behavior,GO:0031103~axon regeneration,GO:0035640~exploration behavior,GO:0043524~negative regulation of neuron apoptotic process,GO:0050890~cognition,	GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0002020~protease binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Extracellular matrix,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule L1-like protein,chain:Processed neural cell adhesion molecule L1-like protein,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,short sequence motif:DGEA,short sequence motif:FIG[AQ]Y,signal peptide,site:Cleavage; by ADAM8,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CDC20B	cell division cycle 20B(CDC20B)	Homo sapiens				GO:1904668~positive regulation of ubiquitin protein ligase activity,		GO:0005515~protein binding,GO:0010997~anaphase-promoting complex binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:Cell division cycle protein 20 homolog B,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,splice variant,
CWH43	cell wall biogenesis 43 C-terminal homolog(CWH43)	Homo sapiens				GO:0006506~GPI anchor biosynthetic process,	GO:0016021~integral component of membrane,		IPR005135:Endonuclease/exonuclease/phosphatase,IPR027317:PGAP2-interacting protein,					Complete proteome,Glycoprotein,GPI-anchor biosynthesis,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:PGAP2-interacting protein,glycosylation site:N-linked (GlcNAc...),region of interest:Required for function in lipid remodeling,sequence variant,transmembrane region,
CLCNKB	chloride voltage-gated channel Kb(CLCNKB)	Homo sapiens				GO:0006810~transport,GO:0007588~excretion,GO:0034220~ion transmembrane transport,GO:1902476~chloride transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0034707~chloride channel complex,	GO:0005247~voltage-gated chloride channel activity,GO:0031404~chloride ion binding,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001807:Chloride channel, voltage gated,IPR002250:Chloride channel ClC-K,IPR014743:Chloride channel, core,	hsa04966:Collecting duct acid secretion,	607364~Bartter syndrome, type 3,613090~Bartter syndrome, type 4b, digenic,		SM00116:CBS,	Alternative splicing,Bartter syndrome,Calcium,CBS domain,Cell membrane,Chloride,Chloride channel,Complete proteome,Deafness,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride channel protein ClC-Kb,domain:CBS 1,domain:CBS 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
CHRNB4	cholinergic receptor nicotinic beta 4 subunit(CHRNB4)	Homo sapiens				GO:0001508~action potential,GO:0006811~ion transport,GO:0006939~smooth muscle contraction,GO:0006940~regulation of smooth muscle contraction,GO:0007165~signal transduction,GO:0007271~synaptic transmission, cholinergic,GO:0007626~locomotory behavior,GO:0035094~response to nicotine,GO:0035095~behavioral response to nicotine,GO:0046928~regulation of neurotransmitter secretion,GO:0051291~protein heterooligomerization,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060084~synaptic transmission involved in micturition,GO:0098655~cation transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005892~acetylcholine-gated channel complex,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0043005~neuron projection,GO:0045211~postsynaptic membrane,	GO:0004889~acetylcholine-activated cation-selective channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0008144~drug binding,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0042166~acetylcholine binding,GO:0046982~protein heterodimerization activity,	IPR002394:Nicotinic acetylcholine receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,IPR027361:Nicotinic acetylcholine-gated receptor, transmembrane domain,	hsa04080:Neuroactive ligand-receptor interaction,hsa04725:Cholinergic synapse,				3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Neuronal acetylcholine receptor subunit beta-4,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
C1orf87	chromosome 1 open reading frame 87(C1orf87)	Homo sapiens							IPR011992:EF-hand-like domain,					Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C1orf87,sequence variant,splice variant,
C15orf56	chromosome 15 open reading frame 56(C15orf56)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C15orf56,sequence variant,
C16orf89	chromosome 16 open reading frame 89(C16orf89)	Homo sapiens				GO:0048741~skeletal muscle fiber development,	GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0042803~protein homodimerization activity,						Alternative splicing,Complete proteome,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C16orf89,sequence conflict,sequence variant,signal peptide,splice variant,
CFAP47	cilia and flagella associated protein 47(CFAP47)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001715:Calponin homology domain,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein CXorf59,glycosylation site:N-linked (GlcNAc...),transmembrane region,
CLDN16	claudin 16(CLDN16)	Homo sapiens				GO:0006811~ion transport,GO:0006875~cellular metal ion homeostasis,GO:0007588~excretion,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:1903830~magnesium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016021~integral component of membrane,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0015095~magnesium ion transmembrane transporter activity,GO:0042802~identical protein binding,	IPR003927:Claudin-16,IPR004031:PMP-22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin, conserved site,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05160:Hepatitis C,	248250~Hypomagnesemia 3, renal,			Cell junction,Cell membrane,Complete proteome,Disease mutation,Ion transport,Magnesium,Membrane,Primary hypomagnesemia,Reference proteome,Tight junction,Transmembrane,Transmembrane helix,Transport,	chain:Claudin-16,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CCDC146	coiled-coil domain containing 146(CCDC146)	Homo sapiens					GO:0005814~centriole,							Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 146,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,sequence conflict,sequence variant,splice variant,
COLGALT2	collagen beta(1-O)galactosyltransferase 2(COLGALT2)	Homo sapiens					GO:0005788~endoplasmic reticulum lumen,	GO:0005515~protein binding,GO:0016740~transferase activity,GO:0050211~procollagen galactosyltransferase activity,	IPR002654:Glycosyl transferase, family 25,	hsa00310:Lysine degradation,hsa00514:Other types of O-glycan biosynthesis,				Complete proteome,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Polymorphism,Proteomics identification,Reference proteome,Signal,Transferase,	chain:Procollagen galactosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:Prevents secretion from ER,signal peptide,
COL4A6	collagen type IV alpha 6 chain(COL4A6)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_amiPathway:Acute Myocardial Infarction,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,h_npp1Pathway:Regulators of Bone Mineralization,h_plateletAppPathway:Platelet Amyloid Precursor Protein Pathway,h_vitCBPathway:Vitamin C in the Brain,		GO:0007155~cell adhesion,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0071230~cellular response to amino acid stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005587~collagen type IV trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005201~extracellular matrix structural constituent,	IPR001442:Collagen IV, non-collagenous,IPR008160:Collagen triple helix repeat,IPR016187:C-type lectin fold,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	300914~Deafness, X-linked 6,		SM00111:C4,	Alternative splicing,Basement membrane,Cell adhesion,Chromosomal rearrangement,Collagen,Complete proteome,Deafness,Disease mutation,Disulfide bond,Extracellular matrix,Glycoprotein,Hydroxylation,Non-syndromic deafness,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-6(IV) chain,disulfide bond,domain:Collagen IV NC1,glycosylation site:N-linked (GlcNAc...),region of interest:7S domain,region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
COL7A1	collagen type VII alpha 1 chain(COL7A1)	Homo sapiens				GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0010951~negative regulation of endopeptidase activity,GO:0030198~extracellular matrix organization,GO:0030574~collagen catabolic process,GO:0035987~endodermal cell differentiation,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005590~collagen type VII trimer,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0030134~ER to Golgi transport vesicle,GO:0031012~extracellular matrix,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR002035:von Willebrand factor, type A,IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR003961:Fibronectin, type III,IPR008160:Collagen triple helix repeat,IPR013783:Immunoglobulin-like fold,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04974:Protein digestion and absorption,	131705~Transient bullous of the newborn,131750~Epidermolysis bullosa dystrophica, AD,131850~Epidermolysis bullosa, pretibial,132000~EBD, Bart type,226600~EBD inversa,226600~Epidermolysis bullosa dystrophica, AR,604129~Epidermolysis bullosa pruriginosa,607523~Toenail dystrophy, isolated,EBD, localisata variant~EBD, localisata variant,		SM00060:FN3,SM00327:VWA,	Alternative splicing,Basement membrane,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Collagen alpha-1(VII) chain,disulfide bond,domain:BPTI/Kunitz inhibitor,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,domain:VWFA 1,domain:VWFA 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Gal...),modified residue,region of interest:Interrupted collagenous region,region of interest:Nonhelical region (NC1),region of interest:Nonhelical region (NC2),region of interest:Triple-helical region,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Reactive bond,splice variant,
CPNE7	copine 7(CPNE7)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0046474~glycerophospholipid biosynthetic process,GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR002035:von Willebrand factor, type A,IPR010734:Copine,				SM00239:C2,SM00327:VWA,	Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Membrane,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Copine-7,domain:C2 1,domain:C2 2,domain:VWFA,sequence variant,splice variant,
CORO6	coronin 6(CORO6)	Homo sapiens				GO:0030036~actin cytoskeleton organization,	GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,GO:0051015~actin filament binding,	IPR001680:WD40 repeat,IPR015048:Domain of unknown function DUF1899,IPR015505:Coronin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,				SM00320:WD40,SM01166:SM01166,	Alternative splicing,Coiled coil,Complete proteome,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Coronin-6,compositionally biased region:Poly-Gly,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,splice variant,
CYSLTR2	cysteinyl leukotriene receptor 2(CYSLTR2)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006955~immune response,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0010942~positive regulation of cell death,GO:0045766~positive regulation of angiogenesis,GO:0061737~leukotriene signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001631~cysteinyl leukotriene receptor activity,GO:0004974~leukotriene receptor activity,GO:0005515~protein binding,GO:0008528~G-protein coupled peptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR004071:Cysteinyl leukotriene receptor,IPR013311:Cysteinyl leukotriene receptor 2,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Cysteinyl leukotriene receptor 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CYP2C9	cytochrome P450 family 2 subfamily C member 9(CYP2C9)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0016098~monoterpenoid metabolic process,GO:0017144~drug metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0019627~urea metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0042737~drug catabolic process,GO:0042738~exogenous drug catabolic process,GO:0043603~cellular amide metabolic process,GO:0055114~oxidation-reduction process,GO:0070989~oxidative demethylation,GO:0097267~omega-hydroxylase P450 pathway,	GO:0005789~endoplasmic reticulum membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0001567~cholesterol 25-hydroxylase activity,GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008144~drug binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0008395~steroid hydroxylase activity,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0018675~(S)-limonene 6-monooxygenase activity,GO:0018676~(S)-limonene 7-monooxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0034875~caffeine oxidase activity,GO:0052741~(R)-limonene 6-monooxygenase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,hsa05204:Chemical carcinogenesis,	122700~Warfarin sensitivity,Tolbutamide poor metabolizer~Tolbutamide poor metabolizer,			3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Heme,Iron,Lipid metabolism,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Polymorphism,Reference proteome,Signal,Steroid metabolism,Sterol metabolism,	chain:Cytochrome P450 2C9,helix,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,strand,turn,
CYP26C1	cytochrome P450 family 26 subfamily C member 1(CYP26C1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006766~vitamin metabolic process,GO:0007417~central nervous system development,GO:0009952~anterior/posterior pattern specification,GO:0014032~neural crest cell development,GO:0034653~retinoic acid catabolic process,GO:0048284~organelle fusion,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0055114~oxidation-reduction process,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0001972~retinoic acid binding,GO:0005506~iron ion binding,GO:0008401~retinoic acid 4-hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,	IPR001128:Cytochrome P450,IPR002403:Cytochrome P450, E-class, group IV,IPR017972:Cytochrome P450, conserved site,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,	614974~Focal facial dermal dysplasia 4,			Complete proteome,Ectodermal dysplasia,Heme,Iron,Membrane,Metal-binding,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 26C1,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,transmembrane region,
CPEB1	cytoplasmic polyadenylation element binding protein 1(CPEB1)	Homo sapiens				GO:0006397~mRNA processing,GO:0006412~translation,GO:0032869~cellular response to insulin stimulus,GO:0071230~cellular response to amino acid stimulus,GO:0071456~cellular response to hypoxia,GO:2000766~negative regulation of cytoplasmic translation,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0000900~translation repressor activity, nucleic acid binding,GO:0003676~nucleic acid binding,GO:0003730~mRNA 3'-UTR binding,GO:0008135~translation factor activity, RNA binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0043022~ribosome binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa04114:Oocyte meiosis,hsa04320:Dorso-ventral axis formation,hsa04914:Progesterone-mediated oocyte maturation,				3D-structure,Activator,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Membrane,Metal-binding,mRNA processing,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Reference proteome,Repeat,Repressor,Ribonucleoprotein,RNA-binding,Synapse,Translation regulation,Zinc,	chain:Cytoplasmic polyadenylation element- binding protein 1,compositionally biased region:Ser-rich,domain:RRM 1,domain:RRM 2,modified residue,mutagenesis site,region of interest:Necessary for stress granule assembly and correct localization in dcp1 bodies,sequence conflict,splice variant,
DOCK3	dedicator of cytokinesis 3(DOCK3)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0017124~SH3 domain binding,	IPR001452:Src homology-3 domain,IPR010703:Dedicator of cytokinesis C-terminal,IPR011511:Variant SH3,IPR016024:Armadillo-type fold,IPR026791:Dedicator of cytokinesis,IPR026800:Dedicator of cytokinesis B,IPR027007:DHR-1 domain,IPR027357:DHR-2 domain,				SM00326:SH3,	Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Guanine-nucleotide releasing factor,Phosphoprotein,Reference proteome,SH3 domain,SH3-binding,	chain:Dedicator of cytokinesis protein 3,compositionally biased region:Ser-rich,domain:DHR-1,domain:DHR-2,domain:SH3,modified residue,short sequence motif:SH3-binding,
DPYSL4	dihydropyrimidinase like 4(DPYSL4)	Homo sapiens				GO:0007399~nervous system development,GO:0070997~neuron death,GO:0097485~neuron projection guidance,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0031005~filamin binding,	IPR006680:Amidohydrolase 1,IPR011059:Metal-dependent hydrolase, composite domain,IPR011778:Hydantoinase/dihydropyrimidinase,					Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Dihydropyrimidinase-related protein 4,modified residue,sequence conflict,
DPP6	dipeptidyl peptidase like 6(DPP6)	Homo sapiens				GO:0006508~proteolysis,GO:0072659~protein localization to plasma membrane,GO:1901379~regulation of potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004177~aminopeptidase activity,GO:0008236~serine-type peptidase activity,GO:0008239~dipeptidyl-peptidase activity,GO:0015459~potassium channel regulator activity,	IPR001375:Peptidase S9, prolyl oligopeptidase, catalytic domain,IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal,		612956~Ventricular fibrillation, paroxysmal familial, 2,616311~Mental retardation, autosomal dominant 33,			3D-structure,Alternative splicing,Aminopeptidase,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Mental retardation,Neurodegeneration,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Dipeptidyl aminopeptidase-like protein 6,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
DMRT2	doublesex and mab-3 related transcription factor 2(DMRT2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007548~sex differentiation,GO:0014807~regulation of somitogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048706~embryonic skeletal system development,GO:2000287~positive regulation of myotome development,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001275:DM DNA-binding,IPR026607:DMRT/protein doublesex/protein male abnormal 3,				SM00301:DM,	Alternative splicing,Complete proteome,DNA-binding,Membrane,Metal-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Zinc,	chain:Doublesex- and mab-3-related transcription factor 2,DNA-binding region:DM,
EFNA2	ephrin A2(EFNA2)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0007411~axon guidance,GO:0021772~olfactory bulb development,GO:0030316~osteoclast differentiation,GO:0046849~bone remodeling,GO:0048013~ephrin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0031594~neuromuscular junction,GO:0043204~perikaryon,	GO:0046875~ephrin receptor binding,	IPR001799:Ephrin,IPR008972:Cupredoxin,IPR019765:Ephrin, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,				3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Signal,	chain:Ephrin-A2,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated asparagine,propeptide:Removed in mature form,sequence conflict,signal peptide,
EPB41L4B	erythrocyte membrane protein band 4.1 like 4B(EPB41L4B)	Homo sapiens				GO:0010628~positive regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0031032~actomyosin structure organization,GO:0042060~wound healing,GO:0045785~positive regulation of cell adhesion,GO:0051549~positive regulation of keratinocyte migration,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005923~bicellular tight junction,GO:0019898~extrinsic component of membrane,GO:0045177~apical part of cell,	GO:0005200~structural constituent of cytoskeleton,GO:0008092~cytoskeletal protein binding,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00295:B41,SM01195:SM01195,SM01196:SM01196,	Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,Tight junction,	chain:Band 4.1-like protein 4B,compositionally biased region:His-rich,domain:FERM,sequence conflict,sequence variant,splice variant,
FAM151A	family with sequence similarity 151 member A(FAM151A)	Homo sapiens					GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR019356:Protein of unknown function DUF2181,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM151A,sequence conflict,sequence variant,splice variant,transmembrane region,
FGFBP1	fibroblast growth factor binding protein 1(FGFBP1)	Homo sapiens				GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0017134~fibroblast growth factor binding,	IPR010510:FGF binding 1,					Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor binding,Membrane,Reference proteome,Secreted,Signal,	chain:Fibroblast growth factor-binding protein 1,disulfide bond,glycosylation site:O-linked (GalNAc...),mutagenesis site,region of interest:Sufficient for interaction with FGF2 and FGF2-induced effects,signal peptide,
FOXI1	forkhead box I1(FOXI1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0009790~embryo development,GO:0042472~inner ear morphogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008301~DNA binding, bending,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018122:Transcription factor, fork head, conserved site,		600791~Enlarged vestibular aqueduct,		SM00339:FH,	Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Forkhead box protein I1,compositionally biased region:Pro-rich,DNA-binding region:Fork-head,sequence conflict,sequence variant,splice variant,
FRZB	frizzled-related protein(FRZB)	Homo sapiens				GO:0001501~skeletal system development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0010721~negative regulation of cell development,GO:0014033~neural crest cell differentiation,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0035567~non-canonical Wnt signaling pathway,GO:0043065~positive regulation of apoptotic process,GO:0045600~positive regulation of fat cell differentiation,GO:0060029~convergent extension involved in organogenesis,GO:0061037~negative regulation of cartilage development,GO:0061053~somite development,GO:0070367~negative regulation of hepatocyte differentiation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090103~cochlea morphogenesis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0017147~Wnt-protein binding,GO:0042813~Wnt-activated receptor activity,	IPR001134:Netrin domain,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR015526:Frizzled/secreted frizzled-related protein,IPR018933:Netrin module, non-TIMP type,IPR020067:Frizzled domain,IPR026556:Secreted frizzled-related protein 3,		165720~Osteoarthritis susceptibility 1,		SM00063:FRI,SM00643:C345C,	Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Secreted frizzled-related protein 3,compositionally biased region:Ser-rich,disulfide bond,domain:FZ,domain:NTR,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
GAL3ST3	galactose-3-O-sulfotransferase 3(GAL3ST3)	Homo sapiens				GO:0005996~monosaccharide metabolic process,GO:0006790~sulfur compound metabolic process,GO:0009247~glycolipid biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0030166~proteoglycan biosynthetic process,GO:0030309~poly-N-acetyllactosamine metabolic process,	GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0001733~galactosylceramide sulfotransferase activity,GO:0030246~carbohydrate binding,GO:0050656~3'-phosphoadenosine 5'-phosphosulfate binding,GO:0050694~galactose 3-O-sulfotransferase activity,GO:0050698~proteoglycan sulfotransferase activity,	IPR009729:Galactose-3-O-sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Glycoprotein,Golgi apparatus,Magnesium,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Galactose-3-O-sulfotransferase 3,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
GABRB2	gamma-aminobutyric acid type A receptor beta2 subunit(GABRB2)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007605~sensory perception of sound,GO:0034220~ion transmembrane transport,GO:0043524~negative regulation of neuron apoptotic process,GO:0051932~synaptic transmission, GABAergic,GO:0060119~inner ear receptor cell development,GO:0060384~innervation,GO:0071420~cellular response to histamine,GO:0090102~cochlea development,GO:1902476~chloride transmembrane transport,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0034707~chloride channel complex,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0070062~extracellular exosome,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005237~inhibitory extracellular ligand-gated ion channel activity,GO:0005254~chloride channel activity,	IPR002289:Gamma-aminobutyric-acid A receptor, beta subunit,IPR006028:Gamma-aminobutyric acid A receptor,IPR006029:Neurotransmitter-gated ion-channel transmembrane domain,IPR006201:Neurotransmitter-gated ion-channel,IPR006202:Neurotransmitter-gated ion-channel ligand-binding,IPR018000:Neurotransmitter-gated ion-channel, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04723:Retrograde endocannabinoid signaling,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,				Alternative splicing,Cell junction,Cell membrane,Chloride,Chloride channel,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Ligand-gated ion channel,Membrane,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Gamma-aminobutyric acid receptor subunit beta-2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GGT6	gamma-glutamyltransferase 6(GGT6)	Homo sapiens				GO:0006508~proteolysis,GO:0006749~glutathione metabolic process,GO:0006750~glutathione biosynthetic process,GO:0019370~leukotriene biosynthetic process,	GO:0016021~integral component of membrane,GO:0031362~anchored component of external side of plasma membrane,GO:0070062~extracellular exosome,	GO:0003840~gamma-glutamyltransferase activity,GO:0036374~glutathione hydrolase activity,	IPR000101:Gamma-glutamyltranspeptidase,	hsa00430:Taurine and hypotaurine metabolism,hsa00460:Cyanoamino acid metabolism,hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,				Acyltransferase,Alternative splicing,Complete proteome,Glutathione biosynthesis,Glycoprotein,Hydrolase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,Zymogen,	chain:Gamma-glutamyltransferase 6 heavy chain,chain:Gamma-glutamyltransferase 6 light chain,compositionally biased region:Poly-Glu,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GJB3	gap junction protein beta 3(GJB3)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001890~placenta development,GO:0007154~cell communication,GO:0007605~sensory perception of sound,GO:0043588~skin development,GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0016021~integral component of membrane,	GO:0005243~gap junction channel activity,	IPR000500:Connexin,IPR002269:Gap junction beta-3 protein (Cx31),IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,		133200~Erythrokeratodermia variabilis et progressiva,220290~Deafness, digenic, GJB2/GJB3,612644~Deafness, autosomal dominant 2B,Deafness, autosomal dominant, with peripheral neuropathy~Deafness, autosomal dominant, with peripheral neuropathy,Deafness, autosomal recessive~Deafness, autosomal recessive,		SM00037:CNX,SM01089:SM01089,	Cell junction,Cell membrane,Complete proteome,Deafness,Disease mutation,Gap junction,Membrane,Non-syndromic deafness,Palmoplantar keratoderma,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-3 protein,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GCGR	glucagon receptor(GCGR)	Homo sapiens				GO:0006091~generation of precursor metabolites and energy,GO:0006887~exocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007584~response to nutrient,GO:0008217~regulation of blood pressure,GO:0009755~hormone-mediated signaling pathway,GO:0042593~glucose homeostasis,GO:0042594~response to starvation,GO:0043547~positive regulation of GTPase activity,GO:0070873~regulation of glycogen metabolic process,GO:0071377~cellular response to glucagon stimulus,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004967~glucagon receptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0017046~peptide hormone binding,	IPR000832:GPCR, family 2, secretin-like,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR003290:GPCR, family 2, glucagon-like peptide-1/glucagon receptor,IPR003291:GPCR, family 2, glucagon receptor,IPR017981:GPCR, family 2-like,IPR017983:GPCR, family 2, secretin-like, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04922:Glucagon signaling pathway,	125853~Diabetes mellitus, noninsulin-dependent,		SM00008:HormR,	3D-structure,Cell membrane,Complete proteome,Diabetes mellitus,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Glucagon receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GRIA2	glutamate ionotropic receptor AMPA type subunit 2(GRIA2)	Homo sapiens		h_fosbPathway:FOSB gene expression and drug abuse,		GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,	GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030666~endocytic vesicle membrane,GO:0032281~AMPA glutamate receptor complex,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004971~AMPA glutamate receptor activity,GO:0005231~excitatory extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005515~protein binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001638:Extracellular solute-binding protein, family 3,IPR001828:Extracellular ligand-binding receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,			SM00079:PBPe,SM00918:SM00918,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,RNA editing,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	binding site:Glutamate,chain:Glutamate receptor 2,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:Glutamate binding,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
GRM8	glutamate metabotropic receptor 8(GRM8)	Homo sapiens				GO:0007196~adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,GO:0007601~visual perception,GO:0007608~sensory perception of smell,GO:0030818~negative regulation of cAMP biosynthetic process,GO:0051966~regulation of synaptic transmission, glutamatergic,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0042734~presynaptic membrane,	GO:0001642~group III metabotropic glutamate receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0008066~glutamate receptor activity,	IPR000144:GPCR, family 3, metabotropic glutamate receptor 8,IPR000162:GPCR, family 3, metabotropic glutamate receptor,IPR000337:GPCR, family 3,IPR001786:GPCR, family 3, metabotropic glutamate receptor 4,IPR001828:Extracellular ligand-binding receptor,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Isopeptide bond,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Metabotropic glutamate receptor 8,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO-1),glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GFPT2	glutamine-fructose-6-phosphate transaminase 2(GFPT2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006002~fructose 6-phosphate metabolic process,GO:0006047~UDP-N-acetylglucosamine metabolic process,GO:0006048~UDP-N-acetylglucosamine biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006541~glutamine metabolic process,GO:1901137~carbohydrate derivative biosynthetic process,	GO:0005829~cytosol,	GO:0004360~glutamine-fructose-6-phosphate transaminase (isomerizing) activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,	IPR001347:Sugar isomerase (SIS),IPR005855:Glucosamine-fructose-6-phosphate aminotransferase, isomerising,IPR017932:Glutamine amidotransferase type 2 domain,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa04931:Insulin resistance,				Aminotransferase,Complete proteome,Glutamine amidotransferase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transferase,	active site:For GATase activity,chain:Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2,domain:Glutamine amidotransferase type-2,domain:SIS 1,domain:SIS 2,modified residue,sequence variant,
GPC3	glypican 3(GPC3)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0009653~anatomical structure morphogenesis,GO:0009948~anterior/posterior axis specification,GO:0010171~body morphogenesis,GO:0010466~negative regulation of peptidase activity,GO:0030203~glycosaminoglycan metabolic process,GO:0030282~bone mineralization,GO:0030316~osteoclast differentiation,GO:0030324~lung development,GO:0030513~positive regulation of BMP signaling pathway,GO:0035116~embryonic hindlimb morphogenesis,GO:0045732~positive regulation of protein catabolic process,GO:0045807~positive regulation of endocytosis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045926~negative regulation of growth,GO:0046326~positive regulation of glucose import,GO:0050680~negative regulation of epithelial cell proliferation,GO:0060976~coronary vasculature development,GO:0072138~mesenchymal cell proliferation involved in ureteric bud development,GO:0072180~mesonephric duct morphogenesis,GO:0072203~cell proliferation involved in metanephros development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0060422~peptidyl-dipeptidase inhibitor activity,	IPR001863:Glypican,IPR015501:Glypican-3,IPR019803:Glypican, conserved site,	hsa05205:Proteoglycans in cancer,	194070~Wilms tumor, somatic,312870~Simpson-Golabi-Behmel syndrome, type 1,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Phosphoprotein,Protease inhibitor,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Glypican-3,chain:Secreted glypican-3,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (heparan sulfate),propeptide:Removed in mature form,sequence variant,signal peptide,
GRHL2	grainyhead like transcription factor 2(GRHL2)	Homo sapiens				GO:0001843~neural tube closure,GO:0003208~cardiac ventricle morphogenesis,GO:0003382~epithelial cell morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0008544~epidermis development,GO:0021915~neural tube development,GO:0034329~cell junction assembly,GO:0035264~multicellular organism growth,GO:0042733~embryonic digit morphogenesis,GO:0043010~camera-type eye development,GO:0044030~regulation of DNA methylation,GO:0045617~negative regulation of keratinocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051973~positive regulation of telomerase activity,GO:0060324~face development,GO:0060463~lung lobe morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:0060672~epithelial cell morphogenesis involved in placental branching,GO:0070830~bicellular tight junction assembly,GO:0090132~epithelium migration,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,	GO:0001161~intronic transcription regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2 transcription factor,		608641~Deafness, autosomal dominant 28,616029~Ectodermal dysplasia/short stature syndrome,			Alternative splicing,Complete proteome,Deafness,Disease mutation,DNA-binding,Dwarfism,Ectodermal dysplasia,Membrane,Non-syndromic deafness,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Grainyhead-like protein 2 homolog,region of interest:Transcription activation,sequence conflict,sequence variant,splice variant,
HP	haptoglobin(HP)	Homo sapiens				GO:0002376~immune system process,GO:0006898~receptor-mediated endocytosis,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0010942~positive regulation of cell death,GO:0042542~response to hydrogen peroxide,GO:0042742~defense response to bacterium,GO:0051354~negative regulation of oxidoreductase activity,GO:0098869~cellular oxidant detoxification,GO:2000296~negative regulation of hydrogen peroxide catabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031838~haptoglobin-hemoglobin complex,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0016209~antioxidant activity,GO:0030492~hemoglobin binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR008292:Haptoglobin,IPR009003:Trypsin-like cysteine/serine peptidase domain,		614081~Anhaptoglobinemia,614081~Hypohaptoglobinemia,	PIRSF001137:haptoglobin,	SM00020:Tryp_SPc,SM00032:CCP,	3D-structure,Acute phase,Alternative splicing,Antibiotic,Antimicrobial,Antioxidant,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemoglobin-binding,Immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease homolog,Signal,Sushi,	chain:Haptoglobin,chain:Haptoglobin alpha chain,chain:Haptoglobin beta chain,chain:Haptoglobin-related protein,disulfide bond,domain:Peptidase S1,domain:Sushi,domain:Sushi 1,domain:Sushi 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
HPR	haptoglobin-related protein(HPR)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,	GO:0005576~extracellular region,GO:0034366~spherical high-density lipoprotein particle,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004252~serine-type endopeptidase activity,GO:0030492~hemoglobin binding,	IPR000436:Sushi/SCR/CCP,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR008292:Haptoglobin,IPR009003:Trypsin-like cysteine/serine peptidase domain,	hsa05143:African trypanosomiasis,		PIRSF001137:haptoglobin,	SM00020:Tryp_SPc,	Alternative splicing,Complete proteome,Disulfide bond,Hemoglobin-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Serine protease homolog,Signal,Sushi,	chain:Haptoglobin,chain:Haptoglobin alpha chain,chain:Haptoglobin beta chain,chain:Haptoglobin-related protein,disulfide bond,domain:Peptidase S1,domain:Sushi,domain:Sushi 1,domain:Sushi 2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
HS6ST2	heparan sulfate 6-O-sulfotransferase 2(HS6ST2)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0015015~heparan sulfate proteoglycan biosynthetic process, enzymatic modification,	GO:0000139~Golgi membrane,GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0017095~heparan sulfate 6-O-sulfotransferase activity,	IPR005331:Sulfotransferase,IPR010635:Heparan sulphate 6-sulfotransferase,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Heparan-sulfate 6-O-sulfotransferase 2,glycosylation site:N-linked (GlcNAc...),region of interest:3'-phosphate binding,region of interest:5'-phosphosulfate-binding,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
HS3ST3A1	heparan sulfate-glucosamine 3-sulfotransferase 3A1(HS3ST3A1)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,GO:0033872~[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,				3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Heparan sulfate glucosamine 3-O- sulfotransferase 3A1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,nucleotide phosphate-binding region:PAPS and substrate,region of interest:Substrate binding,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
HMGA2	high mobility group AT-hook 2(HMGA2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0002062~chondrocyte differentiation,GO:0003131~mesodermal-endodermal cell signaling,GO:0006284~base-excision repair,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007067~mitotic nuclear division,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0008584~male gonad development,GO:0009615~response to virus,GO:0010564~regulation of cell cycle process,GO:0010628~positive regulation of gene expression,GO:0021846~cell proliferation in forebrain,GO:0021983~pituitary gland development,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030261~chromosome condensation,GO:0030325~adrenal gland development,GO:0031052~chromosome breakage,GO:0031507~heterochromatin assembly,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035978~histone H2A-S139 phosphorylation,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0035987~endodermal cell differentiation,GO:0035988~chondrocyte proliferation,GO:0040008~regulation of growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042769~DNA damage response, detection of DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043922~negative regulation by host of viral transcription,GO:0045444~fat cell differentiation,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048333~mesodermal cell differentiation,GO:0048712~negative regulation of astrocyte differentiation,GO:0048762~mesenchymal cell differentiation,GO:0048863~stem cell differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051301~cell division,GO:0060123~regulation of growth hormone secretion,GO:0060428~lung epithelium development,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060501~positive regulation of epithelial cell proliferation involved in lung morphogenesis,GO:0060613~fat pad development,GO:0071158~positive regulation of cell cycle arrest,GO:0090402~oncogene-induced cell senescence,GO:2000036~regulation of stem cell population maintenance,GO:2000648~positive regulation of stem cell proliferation,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000685~positive regulation of cellular response to X-ray,GO:2000774~positive regulation of cellular senescence,GO:2001022~positive regulation of response to DNA damage stimulus,GO:2001033~negative regulation of double-strand break repair via nonhomologous end joining,GO:2001038~regulation of cellular response to drug,	GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032993~protein-DNA complex,GO:0035985~senescence-associated heterochromatin focus,GO:0071141~SMAD protein complex,	GO:0000975~regulatory region DNA binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008301~DNA binding, bending,GO:0031492~nucleosomal DNA binding,GO:0035497~cAMP response element binding,GO:0035500~MH2 domain binding,GO:0035501~MH1 domain binding,GO:0046332~SMAD binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,GO:0070742~C2H2 zinc finger domain binding,	IPR000116:High mobility group, HMG-I/HMG-Y,IPR000637:HMG-I/HMG-Y, DNA-binding, conserved site,IPR017956:AT hook, DNA-binding motif,	hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	150699~Leiomyoma, uterine, somatic,		SM00384:AT_hook,	Acetylation,Alternative splicing,Cell cycle,Cell division,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,DNA condensation,DNA-binding,Growth regulation,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:High mobility group protein HMGI-C,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,modified residue,region of interest:Interaction with E4F1,
HAL	histidine ammonia-lyase(HAL)	Homo sapiens				GO:0006548~histidine catabolic process,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004397~histidine ammonia-lyase activity,GO:0016841~ammonia-lyase activity,	IPR001106:Aromatic amino acid lyase,IPR005921:Histidine ammonia-lyase,IPR008948:L-Aspartase-like,IPR021922:Protein of unknown function DUF3534,IPR022313:Phenylalanine/histidine ammonia-lyases, active site,IPR024083:Fumarase/histidase, N-terminal,	hsa00340:Histidine metabolism,hsa01100:Metabolic pathways,	235800~Histidinemia,			Alternative splicing,Complete proteome,Disease mutation,Histidine metabolism,Lyase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Histidine ammonia-lyase,cross-link:5-imidazolinone (Ala-Gly),modified residue,sequence variant,
HRG	histidine rich glycoprotein(HRG)	Homo sapiens				GO:0001525~angiogenesis,GO:0002576~platelet degranulation,GO:0002839~positive regulation of immune response to tumor cell,GO:0006935~chemotaxis,GO:0007162~negative regulation of cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0010543~regulation of platelet activation,GO:0010593~negative regulation of lamellipodium assembly,GO:0010951~negative regulation of endopeptidase activity,GO:0015886~heme transport,GO:0016525~negative regulation of angiogenesis,GO:0030168~platelet activation,GO:0030193~regulation of blood coagulation,GO:0030308~negative regulation of cell growth,GO:0032956~regulation of actin cytoskeleton organization,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0042730~fibrinolysis,GO:0043065~positive regulation of apoptotic process,GO:0043254~regulation of protein complex assembly,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050832~defense response to fungus,GO:0051894~positive regulation of focal adhesion assembly,GO:0051918~negative regulation of fibrinolysis,GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway,GO:2000504~positive regulation of blood vessel remodeling,GO:2001027~negative regulation of endothelial cell chemotaxis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0031093~platelet alpha granule lumen,GO:0036019~endolysosome,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008270~zinc ion binding,GO:0019865~immunoglobulin binding,GO:0020037~heme binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0046872~metal ion binding,	IPR000010:Proteinase inhibitor I25, cystatin,		613116~Thrombophilia due to elevated HRG,613116~Thrombophilia due to HRG deficiency,		SM00043:CY,	Angiogenesis,Blood coagulation,Chemotaxis,Cleavage on pair of basic residues,Complete proteome,Copper,Direct protein sequencing,Disease mutation,Disulfide bond,Fibrinolysis,Glycoprotein,Hemostasis,Heparin-binding,Metal-binding,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Thrombophilia,Zinc,	chain:Histidine-rich glycoprotein,compositionally biased region:His/Pro-rich,compositionally biased region:Pro-rich,disulfide bond,domain:Cystatin 1,domain:Cystatin 2,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
HAGHL	hydroxyacylglutathione hydrolase-like(HAGHL)	Homo sapiens				GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,		GO:0004416~hydroxyacylglutathione hydrolase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001279:Beta-lactamase-like,IPR017782:Hydroxyacylglutathione hydrolase,	hsa00620:Pyruvate metabolism,			SM00849:SM00849,	Alternative splicing,Complete proteome,Hydrolase,Metal-binding,Proteomics identification,Reference proteome,Zinc,	chain:Hydroxyacylglutathione hydrolase-like protein,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,splice variant,
INHBE	inhibin beta E subunit(INHBE)	Homo sapiens				GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0008083~growth factor activity,	IPR001318:Inhibin, beta C subunit,IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Growth factor,Hormone,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Inhibin beta E chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
INPP5J	inositol polyphosphate-5-phosphatase J(INPP5J)	Homo sapiens				GO:0006661~phosphatidylinositol biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0031115~negative regulation of microtubule polymerization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0043647~inositol phosphate metabolic process,GO:0046856~phosphatidylinositol dephosphorylation,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030426~growth cone,GO:0043198~dendritic shaft,	GO:0004439~phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,GO:0004445~inositol-polyphosphate 5-phosphatase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0017124~SH3 domain binding,GO:0034485~phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,GO:0052658~inositol-1,4,5-trisphosphate 5-phosphatase activity,GO:0052659~inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,	IPR000300:Inositol polyphosphate-related phosphatase,IPR005135:Endonuclease/exonuclease/phosphatase,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			SM00128:IPPc,	Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3-binding,	chain:Phosphatidylinositol 4,5-bisphosphate 5- phosphatase A,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,region of interest:Catalytic,region of interest:Required for ruffle localization,sequence conflict,sequence variant,short sequence motif:RSXSXX motif 1,short sequence motif:RSXSXX motif 2,short sequence motif:RSXSXX motif 3,short sequence motif:RSXSXX motif 4,short sequence motif:RSXSXX motif 5,short sequence motif:SH3-binding,splice variant,
IGF2	insulin like growth factor 2(IGF2)	Homo sapiens				GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001934~positive regulation of protein phosphorylation,GO:0002576~platelet degranulation,GO:0006006~glucose metabolic process,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0038028~insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0042104~positive regulation of activated T cell proliferation,GO:0043085~positive regulation of catalytic activity,GO:0043410~positive regulation of MAPK cascade,GO:0044267~cellular protein metabolic process,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0045840~positive regulation of mitotic nuclear division,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051781~positive regulation of cell division,GO:0051897~positive regulation of protein kinase B signaling,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:2000273~positive regulation of receptor activity,GO:2000467~positive regulation of glycogen (starch) synthase activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,	GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0030546~receptor activator activity,GO:0043539~protein serine/threonine kinase activator activity,	IPR013576:Insulin-like growth factor II E-peptide, C-terminal,IPR016179:Insulin-like,IPR022334:Insulin-like growth factor II,IPR022350:Insulin-like growth factor,IPR022352:Insulin family,IPR022353:Insulin, conserved site,	hsa05205:Proteoglycans in cancer,	616489~Growth restriction, severe, with distinctive facies,		SM00078:IlGF,	3D-structure,Alternative splicing,Carbohydrate metabolism,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Dwarfism,Glucose metabolism,Glycoprotein,Growth factor,Hormone,Mitogen,Osteogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Insulin-like growth factor II,chain:Insulin-like growth factor II Ala-25 Del,disulfide bond,glycosylation site:O-linked (GalNAc...),helix,peptide:Insulin A chain,peptide:Insulin B chain,peptide:Preptin,propeptide:C peptide,propeptide:E peptide,region of interest:A,region of interest:B,region of interest:C,region of interest:D,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
IGFBP1	insulin like growth factor binding protein 1(IGFBP1)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0001558~regulation of cell growth,GO:0007165~signal transduction,GO:0007568~aging,GO:0008286~insulin receptor signaling pathway,GO:0030307~positive regulation of cell growth,GO:0036499~PERK-mediated unfolded protein response,GO:0042246~tissue regeneration,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0044267~cellular protein metabolic process,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005102~receptor binding,GO:0005520~insulin-like growth factor binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin type-1,IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009168:Insulin-like growth factor binding protein,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,IPR022321:Insulin-like growth factor-binding protein family 1-6, chordata,IPR022322:Insulin-like growth factor-binding protein 1,				SM00121:IB,SM00211:TY,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Growth factor binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Insulin-like growth factor-binding protein 1,disulfide bond,domain:IGFBP N-terminal,domain:Thyroglobulin type-1,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,strand,turn,
INSRR	insulin receptor related receptor(INSRR)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030238~male sex determination,GO:0031532~actin cytoskeleton reorganization,GO:0046777~protein autophosphorylation,GO:0071469~cellular response to alkaline pH,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043560~insulin receptor substrate binding,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR003961:Fibronectin, type III,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR008266:Tyrosine-protein kinase, active site,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR013783:Immunoglobulin-like fold,IPR016246:Tyrosine-protein kinase, insulin-like receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04810:Regulation of actin cytoskeleton,hsa05215:Prostate cancer,		PIRSF000620:insulin receptor,	SM00060:FN3,SM00219:TyrKc,SM00261:FU,	ATP-binding,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Insulin receptor-related protein,chain:Insulin receptor-related protein alpha chain,chain:Insulin receptor-related protein beta chain,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ITIH1	inter-alpha-trypsin inhibitor heavy chain 1(ITIH1)	Homo sapiens				GO:0010951~negative regulation of endopeptidase activity,GO:0030212~hyaluronan metabolic process,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005509~calcium ion binding,	IPR002035:von Willebrand factor, type A,IPR010600:Inter-alpha-trypsin inhibitor heavy chain, C-terminal,IPR013694:VIT domain,				SM00327:VWA,SM00609:VIT,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Phosphoprotein,Polymorphism,Protease inhibitor,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Inter-alpha-trypsin inhibitor heavy chain H1,disulfide bond,domain:VIT,domain:VWFA,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...) (complex),glycosylation site:O-linked (GalNAc...),glycosylation site:S-linked (Hex...),modified residue,region of interest:Hyaluronan-binding,sequence conflict,sequence variant,short sequence motif:Phagocytosis uptake signal,signal peptide,
IL20RB	interleukin 20 receptor subunit beta(IL20RB)	Homo sapiens				GO:0001808~negative regulation of type IV hypersensitivity,GO:0002437~inflammatory response to antigenic stimulus,GO:0002765~immune response-inhibiting signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0032689~negative regulation of interferon-gamma production,GO:0032703~negative regulation of interleukin-2 production,GO:0032733~positive regulation of interleukin-10 production,GO:0032753~positive regulation of interleukin-4 production,GO:0042130~negative regulation of T cell proliferation,GO:0048873~homeostasis of number of cells within a tissue,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004896~cytokine receptor activity,GO:0042015~interleukin-20 binding,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR015373:Interferon alpha/beta receptor, beta chain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,				3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-20 receptor subunit beta,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
IRX2	iroquois homeobox 2(IRX2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0072086~specification of loop of Henle identity,GO:0072272~proximal/distal pattern formation involved in metanephric nephron development,	GO:0005634~nucleus,	GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR003893:Iroquois-class homeodomain protein,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,				SM00389:HOX,SM00548:IRO,	Complete proteome,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,	chain:Iroquois-class homeodomain protein irx-2,DNA-binding region:Homeobox; TALE-type,
ISM1	isthmin 1(ISM1)	Homo sapiens					GO:0005576~extracellular region,		IPR000884:Thrombospondin, type 1 repeat,IPR005533:AMOP,				SM00209:TSP1,SM00723:AMOP,	Complete proteome,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Isthmin-1,disulfide bond,domain:AMOP,domain:TSP type-1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
KLK1	kallikrein 1(KLK1)	Homo sapiens				GO:0006508~proteolysis,	GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04614:Renin-angiotensin system,hsa04961:Endocrine and other factor-regulated calcium reabsorption,	615953~Kallikrein, decreased urinary activity of,		SM00020:Tryp_SPc,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Kallikrein-1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,glycosylation site:O-linked (GalNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
KRT15	keratin 15(KRT15)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008544~epidermis development,	GO:0005634~nucleus,GO:0005882~intermediate filament,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0097110~scaffold protein binding,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR009053:Prefoldin,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Alternative splicing,Coiled coil,Complete proteome,Intermediate filament,Keratin,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Keratin, type I cytoskeletal 15,compositionally biased region:Gly-rich,compositionally biased region:Poly-Gly,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence variant,
KRT20	keratin 20(KRT20)	Homo sapiens				GO:0006915~apoptotic process,GO:0033554~cellular response to stress,GO:0045109~intermediate filament organization,GO:0050708~regulation of protein secretion,	GO:0005737~cytoplasm,GO:0005882~intermediate filament,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Apoptosis,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Intermediate filament,Keratin,Phosphoprotein,Polymorphism,Reference proteome,	chain:Keratin, type I cytoskeletal 20,modified residue,mutagenesis site,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Cleavage; by caspases,
KLRG2	killer cell lectin like receptor G2(KLRG2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,	Alternative splicing,Complete proteome,Disulfide bond,Lectin,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Killer cell lectin-like receptor subfamily G member 2,compositionally biased region:Pro-rich,disulfide bond,domain:C-type lectin,modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
KSR2	kinase suppressor of ras 2(KSR2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR025561:Kinase suppressor of RAS, SAM-like domain,	hsa04014:Ras signaling pathway,			SM00109:C1,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	chain:Kinase suppressor of Ras 2,compositionally biased region:Pro-rich,domain:Protein kinase,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
KLB	klotho beta(KLB)	Homo sapiens				GO:0000165~MAPK cascade,GO:0005975~carbohydrate metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043547~positive regulation of GTPase activity,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0090080~positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,GO:1901657~glycosyl compound metabolic process,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004871~signal transducer activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005104~fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0008422~beta-glucosidase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0017134~fibroblast growth factor binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR001360:Glycoside hydrolase, family 1,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,					Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Beta-klotho,glycosylation site:N-linked (GlcNAc...),region of interest:Glycosyl hydrolase-1 1,region of interest:Glycosyl hydrolase-1 2,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LAMA1	laminin subunit alpha 1(LAMA1)	Homo sapiens		h_prionPathway:Prion Pathway,		GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0030334~regulation of cell migration,GO:0045995~regulation of embryonic development,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005606~laminin-1 complex,GO:0005608~laminin-3 complex,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005102~receptor binding,GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR000034:Laminin B type IV,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR009254:Laminin I,IPR010307:Laminin II,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	615960~Poretti-Boltshauser syndrome,		SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,SM00281:LamB,SM00282:LamG,	Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit alpha-1,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 10,domain:Laminin EGF-like 11,domain:Laminin EGF-like 12,domain:Laminin EGF-like 13,domain:Laminin EGF-like 14; first part,domain:Laminin EGF-like 14; second part,domain:Laminin EGF-like 15,domain:Laminin EGF-like 16,domain:Laminin EGF-like 17,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5; first part,domain:Laminin EGF-like 5; second part,domain:Laminin EGF-like 6,domain:Laminin EGF-like 7,domain:Laminin EGF-like 8,domain:Laminin EGF-like 9,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,domain:Laminin G-like 5,domain:Laminin IV type A 1,domain:Laminin IV type A 2,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Domain II and I,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,
LAMB3	laminin subunit beta 3(LAMB3)	Homo sapiens				GO:0007155~cell adhesion,GO:0008544~epidermis development,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0031581~hemidesmosome assembly,GO:0035987~endodermal cell differentiation,GO:0050873~brown fat cell differentiation,	GO:0005576~extracellular region,GO:0005610~laminin-5 complex,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0032403~protein complex binding,	IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR008979:Galactose-binding domain-like,IPR013032:EGF-like, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	104530~Amelogenesis imperfecta, type IA,226650~Epidermolysis bullosa, junctional, non-Herlitz type,226700~Epidermolysis bullosa, junctional, Herlitz type,		SM00136:LamNT,SM00180:EGF_Lam,	Amelogenesis imperfecta,Basement membrane,Cell adhesion,Coiled coil,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epidermolysis bullosa,Extracellular matrix,Glycoprotein,Laminin EGF-like domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Laminin subunit beta-3,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin EGF-like 4,domain:Laminin EGF-like 5,domain:Laminin EGF-like 6,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Domain alpha,region of interest:Domain I,region of interest:Domain II,sequence conflict,sequence variant,signal peptide,
LGR5	leucine rich repeat containing G protein-coupled receptor 5(LGR5)	Homo sapiens				GO:0001942~hair follicle development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0009994~oocyte differentiation,GO:0042127~regulation of cell proliferation,GO:0048839~inner ear development,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0032588~trans-Golgi network membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0016500~protein-hormone receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000372:Leucine-rich repeat-containing N-terminal,IPR001611:Leucine-rich repeat,IPR002131:Glycoprotein hormone receptor,IPR003591:Leucine-rich repeat, typical subtype,IPR017452:GPCR, rhodopsin-like, 7TM,				SM00013:LRRNT,SM00369:LRR_TYP,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Golgi apparatus,Leucine-rich repeat,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Leucine-rich repeat-containing G-protein coupled receptor 5,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
LBP	lipopolysaccharide binding protein(LBP)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,	H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,		GO:0002232~leukocyte chemotaxis involved in inflammatory response,GO:0002281~macrophage activation involved in immune response,GO:0006953~acute-phase response,GO:0006968~cellular defense response,GO:0008228~opsonization,GO:0015920~lipopolysaccharide transport,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032490~detection of molecule of bacterial origin,GO:0032496~response to lipopolysaccharide,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034142~toll-like receptor 4 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043032~positive regulation of macrophage activation,GO:0044130~negative regulation of growth of symbiont in host,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0060265~positive regulation of respiratory burst involved in inflammatory response,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0070891~lipoteichoic acid binding,	IPR001124:Lipid-binding serum glycoprotein, C-terminal,IPR017942:Lipid-binding serum glycoprotein, N-terminal,IPR017943:Bactericidal permeability-increasing protein, alpha/beta domain,IPR017954:Lipid-binding serum glycoprotein, conserved site,	hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05152:Tuberculosis,		PIRSF002417:lipid-binding protein, LBP type,	SM00328:BPI1,SM00329:BPI2,	Antibiotic,Antimicrobial,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Lipid transport,Membrane,Polymorphism,Reference proteome,Secreted,Signal,Transport,	chain:Lipopolysaccharide-binding protein,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
LINC00488	long intergenic non-protein coding RNA 488(LINC00488)	Homo sapiens													chain:Putative uncharacterized protein C3orf66,
MFSD2A	major facilitator superfamily domain containing 2A(MFSD2A)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0015908~fatty acid transport,GO:0021766~hippocampus development,GO:0045056~transcytosis,GO:0051977~lysophospholipid transport,GO:0055085~transmembrane transport,GO:0060856~establishment of blood-brain barrier,GO:1990379~lipid transport across blood brain barrier,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005548~phospholipid transporter activity,GO:0015245~fatty acid transporter activity,GO:0015293~symporter activity,GO:0051978~lysophospholipid transporter activity,	IPR020846:Major facilitator superfamily domain,		616486~Microcephaly 15, primary, autosomal recessive,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Endoplasmic reticulum,Glycoprotein,Lipid transport,Membrane,Primary microcephaly,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Major facilitator superfamily domain- containing protein 2A,compositionally biased region:Poly-Lys,sequence conflict,splice variant,transmembrane region,
MAL	mal, T-cell differentiation protein(MAL)	Homo sapiens		h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,		GO:0001766~membrane raft polarization,GO:0006915~apoptotic process,GO:0007417~central nervous system development,GO:0030154~cell differentiation,GO:0042552~myelination,GO:0045176~apical protein localization,GO:0055085~transmembrane transport,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0019898~extrinsic component of membrane,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0008289~lipid binding,GO:0015267~channel activity,GO:0016505~peptidase activator activity involved in apoptotic process,GO:0019911~structural constituent of myelin sheath,	IPR008253:Marvel,IPR013295:Myelin and lymphocyte (MAL) protein,					Alternative splicing,Complete proteome,Lipoprotein,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Myelin and lymphocyte protein,domain:MARVEL,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MMP13	matrix metallopeptidase 13(MMP13)	Homo sapiens				GO:0001958~endochondral ossification,GO:0003417~growth plate cartilage development,GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030282~bone mineralization,GO:0030574~collagen catabolic process,GO:0044267~cellular protein metabolic process,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,	GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0008270~zinc ion binding,	IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR016293:Peptidase M10A, metazoans,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,		602111~Metaphyseal anadysplasia 1,602111~Spondyloepimetaphyseal dysplasia, Missouri type,	PIRSF001191:matrix metalloproteinase, stromelysin type,	SM00120:HX,SM00235:ZnMc,	3D-structure,Calcium,Collagen,Collagen degradation,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Dwarfism,Extracellular matrix,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Zinc,Zymogen,	chain:Collagenase 3,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Calcium 4; via carbonyl oxygen,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2; catalytic,metal ion-binding site:Zinc 2; in inhibited form,propeptide:Activation peptide,sequence variant,short sequence motif:Cysteine switch,signal peptide,strand,turn,
MMP7	matrix metallopeptidase 7(MMP7)	Homo sapiens				GO:0006508~proteolysis,GO:0007568~aging,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0031667~response to nutrient levels,GO:0044849~estrous cycle,GO:0060135~maternal process involved in female pregnancy,GO:0071260~cellular response to mechanical stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0009986~cell surface,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008201~heparin binding,GO:0008270~zinc ion binding,	IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR021158:Peptidase M10A, cysteine switch, zinc binding site,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,	hsa04310:Wnt signaling pathway,			SM00235:ZnMc,	3D-structure,Calcium,Collagen degradation,Complete proteome,Direct protein sequencing,Extracellular matrix,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal,Zinc,Zymogen,	chain:Matrilysin,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2; catalytic,metal ion-binding site:Zinc 2; in inhibited form,propeptide:Activation peptide,sequence variant,short sequence motif:Cysteine switch,signal peptide,strand,turn,
MS4A10	membrane spanning 4-domains A10(MS4A10)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007237:CD20-like,					Complete proteome,Membrane,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Membrane-spanning 4-domains subfamily A member 10,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
MSLN	mesothelin(MSLN)	Homo sapiens				GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0031016~pancreas development,	GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0031225~anchored component of membrane,	GO:0005515~protein binding,	IPR010335:Mesothelin,IPR026664:Stereocilin related,					3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Golgi apparatus,GPI-anchor,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Megakaryocyte-potentiating factor,chain:Mesothelin,chain:Mesothelin, cleaved form,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,region of interest:Required for megakaryocyte-potentiating factor activity,sequence conflict,sequence variant,signal peptide,splice variant,
MT1G	metallothionein 1G(MT1G)	Homo sapiens				GO:0030224~monocyte differentiation,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042117~monocyte activation,GO:0045926~negative regulation of growth,GO:0071276~cellular response to cadmium ion,GO:0071280~cellular response to copper ion,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,	hsa04978:Mineral absorption,				Acetylation,Alternative splicing,Cadmium,Complete proteome,Copper,Direct protein sequencing,Metal-binding,Metal-thiolate cluster,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,	chain:Metallothionein-1G,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,modified residue,region of interest:Alpha,region of interest:Beta,splice variant,
MOGAT2	monoacylglycerol O-acyltransferase 2(MOGAT2)	Homo sapiens				GO:0006071~glycerol metabolic process,GO:0006651~diacylglycerol biosynthetic process,GO:0019432~triglyceride biosynthetic process,GO:0050892~intestinal absorption,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0003846~2-acylglycerol O-acyltransferase activity,GO:0016407~acetyltransferase activity,	IPR007130:Diacylglycerol acyltransferase,	hsa00561:Glycerolipid metabolism,hsa04975:Fat digestion and absorption,				Acyltransferase,Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycerol metabolism,Lipid biosynthesis,Lipid metabolism,Membrane,Polymorphism,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	chain:2-acylglycerol O-acyltransferase 2,sequence conflict,sequence variant,splice variant,transmembrane region,
MEGF6	multiple EGF like domains 6(MEGF6)	Homo sapiens					GO:0005576~extracellular region,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Multiple epidermal growth factor-like domains protein 6,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19,domain:EGF-like 20,domain:EGF-like 21,domain:EGF-like 22,domain:EGF-like 23,domain:EGF-like 24,domain:EGF-like 25,domain:EGF-like 26,domain:EGF-like 27,domain:EGF-like 2; calcium-binding,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8; calcium-binding,domain:EGF-like 9,domain:EMI,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
MYO3B	myosin IIIB(MYO3B)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0007601~visual perception,GO:0050896~response to stimulus,	GO:0005737~cytoplasm,GO:0016459~myosin complex,	GO:0003774~motor activity,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,	IPR000048:IQ motif, EF-hand binding site,IPR000719:Protein kinase, catalytic domain,IPR001609:Myosin head, motor domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00015:IQ,SM00220:S_TKc,SM00242:MYSc,	Actin-binding,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Motor protein,Myosin,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sensory transduction,Serine/threonine-protein kinase,Transferase,Vision,	active site:Proton acceptor,binding site:ATP,chain:Myosin-IIIb,domain:IQ 1,domain:IQ 2,domain:Myosin head-like,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
NTNG1	netrin G1(NTNG1)	Homo sapiens				GO:0007409~axonogenesis,	GO:0046658~anchored component of plasma membrane,	GO:0005515~protein binding,	IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR008211:Laminin, N-terminal,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules (CAMs),			SM00136:LamNT,SM00180:EGF_Lam,SM00181:EGF,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Laminin EGF-like domain,Lipoprotein,Membrane,Neurogenesis,Reference proteome,Repeat,Signal,	chain:Netrin-G1,disulfide bond,domain:Laminin EGF-like 1,domain:Laminin EGF-like 2,domain:Laminin EGF-like 3,domain:Laminin N-terminal,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence conflict,signal peptide,splice variant,
NMRK2	nicotinamide riboside kinase 2(NMRK2)	Homo sapiens				GO:0009435~NAD biosynthetic process,GO:0016310~phosphorylation,GO:0045662~negative regulation of myoblast differentiation,	GO:0005622~intracellular,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0046872~metal ion binding,GO:0050262~ribosylnicotinamide kinase activity,	IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00760:Nicotinate and nicotinamide metabolism,hsa01100:Metabolic pathways,				Alternative splicing,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Polymorphism,Pyridine nucleotide biosynthesis,Reference proteome,Transferase,	active site:Proton acceptor,binding site:ATP,binding site:Substrate,chain:Nicotinamide riboside kinase 2,metal ion-binding site:Magnesium,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
NUPR2	nuclear protein 2, transcriptional regulator(NUPR2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0009267~cellular response to starvation,GO:0071157~negative regulation of cell cycle arrest,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR018792:Nuclear phosphoprotein p8, DNA binding,					Cell cycle,Complete proteome,Growth arrest,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Uncharacterized protein LOC389493,
ODAM	odontogenic, ameloblast asssociated(ODAM)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0006954~inflammatory response,GO:0010628~positive regulation of gene expression,GO:0031214~biomineral tissue development,GO:0032956~regulation of actin cytoskeleton organization,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043547~positive regulation of GTPase activity,GO:0044267~cellular protein metabolic process,GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0043205~fibril,GO:0071944~cell periphery,	GO:0005515~protein binding,	IPR026802:Odontogenic ameloblast-associated protein,					Biomineralization,Complete proteome,Cytoplasm,Glycoprotein,Nucleus,Polymorphism,Reference proteome,Secreted,Signal,	chain:Odontogenic ameloblast-associated protein,compositionally biased region:Gln-rich,glycosylation site:O-linked (GalNAc...),sequence variant,signal peptide,
OR7D2	olfactory receptor family 7 subfamily D member 2(OR7D2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007186~G-protein coupled receptor signaling pathway,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 7D2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
OOEP	oocyte expressed protein(OOEP)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006468~protein phosphorylation,GO:0007566~embryo implantation,GO:0009566~fertilization,GO:0009880~embryonic pattern specification,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0043623~cellular protein complex assembly,	GO:0005938~cell cortex,GO:0043234~protein complex,GO:0045177~apical part of cell,	GO:0003723~RNA binding,						Complete proteome,Cytoplasm,Polymorphism,Reference proteome,	chain:Oocyte-expressed protein homolog,domain:KH; atypical,sequence variant,
OVCH2	ovochymase 2 (gene/pseudogene)(OVCH2)	Homo sapiens				GO:0006508~proteolysis,	GO:0005576~extracellular region,	GO:0004252~serine-type endopeptidase activity,GO:0046872~metal ion binding,	IPR000859:CUB domain,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,SM00042:CUB,	Calcium,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Metal-binding,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Ovochymase-2,disulfide bond,domain:CUB 1,domain:CUB 2,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,modified residue,propeptide:Activation peptide,sequence variant,signal peptide,
OXGR1	oxoglutarate receptor 1(OXGR1)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,					Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:2-oxoglutarate receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PAK6	p21 (RAC1) activated kinase 6(PAK6)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,		GO:0000278~mitotic cell cycle,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007010~cytoskeleton organization,GO:0023014~signal transduction by protein phosphorylation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,	GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000095:PAK-box/P21-Rho-binding,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04660:T cell receptor signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05211:Renal cell carcinoma,			SM00285:PBD,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PAK 6,domain:CRIB,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Linker,sequence variant,strand,turn,
LOC105371267	p53-regulated lncRNA 1(LOC105371267)	Homo sapiens												Complete proteome,Reference proteome,
PITX1	paired like homeodomain 1(PITX1)	Homo sapiens				GO:0001501~skeletal system development,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0009653~anatomical structure morphogenesis,GO:0014707~branchiomeric skeletal muscle development,GO:0021983~pituitary gland development,GO:0035116~embryonic hindlimb morphogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048625~myoblast fate commitment,GO:0051216~cartilage development,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR003654:OAR domain,IPR009057:Homeodomain-like,IPR016233:Homeobox protein Pitx/unc30,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,		119800~Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly,186550~Liebenberg syndrome,	PIRSF000563:homeobox protein, Pitx/Unc30 types,	SM00389:HOX,	Acetylation,Activator,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Pituitary homeobox 1,compositionally biased region:Poly-Pro,DNA-binding region:Homeobox,modified residue,region of interest:Interacts with PIT-1,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:OAR,
PAPPA2	pappalysin 2(PAPPA2)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006508~proteolysis,GO:0044267~cellular protein metabolic process,GO:0060349~bone morphogenesis,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0070062~extracellular exosome,	GO:0004222~metalloendopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,	IPR000436:Sushi/SCR/CCP,IPR000800:Notch domain,IPR003961:Fibronectin, type III,IPR006558:LamG-like jellyroll fold,IPR008754:Peptidase M43, pregnancy-associated plasma-A,IPR011936:Myxococcus cysteine-rich repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR026918:Pappalysin-2,				SM00004:NL,SM00032:CCP,SM00560:LamGL,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Repeat,Secreted,Signal,Sushi,Zinc,Zymogen,	chain:Pappalysin-2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Thr,disulfide bond,domain:Sushi 1,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,mutagenesis site,region of interest:Metalloprotease,sequence conflict,sequence variant,signal peptide,splice variant,
PVALB	parvalbumin(PVALB)	Homo sapiens				GO:0051480~regulation of cytosolic calcium ion concentration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR002048:EF-hand domain,IPR008080:Parvalbumin,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	3D-structure,Acetylation,Calcium,Complete proteome,Direct protein sequencing,Metal-binding,Muscle protein,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:Parvalbumin alpha,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,mutagenesis site,sequence conflict,strand,turn,
PI3	peptidase inhibitor 3(PI3)	Homo sapiens				GO:0007620~copulation,GO:0010951~negative regulation of endopeptidase activity,	GO:0005578~proteinaceous extracellular matrix,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002098:Seminal vesicle protein I,IPR008197:Whey acidic protein-type  4-disulphide core,IPR019541:Trappin protein transglutaminase-binding repeat,				SM00217:WAP,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Polymorphism,Protease inhibitor,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Elafin,disulfide bond,domain:WAP,helix,region of interest:2 X tandem repeats of SVP-1 like motif,repeat:SVP-1 clotting 1,repeat:SVP-1 clotting 2,sequence conflict,sequence variant,signal peptide,strand,
PGLYRP1	peptidoglycan recognition protein 1(PGLYRP1)	Homo sapiens		h_tollPathway:Toll-Like Receptor Pathway,		GO:0002221~pattern recognition receptor signaling pathway,GO:0006955~immune response,GO:0009253~peptidoglycan catabolic process,GO:0016045~detection of bacterium,GO:0032689~negative regulation of interferon-gamma production,GO:0032827~negative regulation of natural killer cell differentiation involved in immune response,GO:0044117~growth of symbiont in host,GO:0045087~innate immune response,GO:0050728~negative regulation of inflammatory response,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0008745~N-acetylmuramoyl-L-alanine amidase activity,GO:0016019~peptidoglycan receptor activity,GO:0042834~peptidoglycan binding,	IPR002502:N-acetylmuramoyl-L-alanine amidase domain,IPR006619:Peptidoglycan recognition protein family domain, metazoa/bacteria,IPR015510:Peptidoglycan recognition protein,IPR017331:Peptidoglycan recognition protein, PGRP-S,			PIRSF037945:peptidoglycan recognition protein, PGRP-S type,	SM00644:Ami_2,SM00701:PGRP,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Innate immunity,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:Peptidoglycan recognition protein 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
PIK3C2G	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma(PIK3C2G)	Homo sapiens		h_ccr3Pathway:CCR3 signaling in Eosinophils,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,		GO:0006661~phosphatidylinositol biosynthetic process,GO:0006935~chemotaxis,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0039694~viral RNA genome replication,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,	GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphatidylinositol 3-kinase complex,	GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016307~phosphatidylinositol phosphate kinase activity,GO:0035005~1-phosphatidylinositol-4-phosphate 3-kinase activity,GO:0035091~phosphatidylinositol binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000341:Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain,IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR001263:Phosphoinositide 3-kinase, accessory (PIK) domain,IPR001683:Phox homologous domain,IPR002420:Phosphatidylinositol 3-kinase C2 (PI3K C2) domain,IPR011009:Protein kinase-like domain,IPR015433:Phosphatidylinositol Kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,	hsa00562:Inositol phosphate metabolism,hsa01100:Metabolic pathways,hsa04070:Phosphatidylinositol signaling system,			SM00142:PI3K_C2,SM00145:PI3Ka,SM00146:PI3Kc,SM00239:C2,SM00312:PX,	3D-structure,ATP-binding,Chemotaxis,Complete proteome,Kinase,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Transferase,	chain:Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma,domain:C2,domain:PI3K/PI4K,domain:PX,modified residue,sequence conflict,sequence variant,
PLA2G4F	phospholipase A2 group IVF(PLA2G4F)	Homo sapiens				GO:0001516~prostaglandin biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0008152~metabolic process,GO:0009395~phospholipid catabolic process,GO:0036148~phosphatidylglycerol acyl-chain remodeling,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0050482~arachidonic acid secretion,GO:0071236~cellular response to antibiotic,GO:0071407~cellular response to organic cyclic compound,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0031982~vesicle,GO:0032587~ruffle membrane,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0046872~metal ion binding,GO:0047498~calcium-dependent phospholipase A2 activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR002642:Lysophospholipase, catalytic domain,IPR016035:Acyl transferase/acyl hydrolase/lysophospholipase,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04611:Platelet activation,hsa04664:Fc epsilon RI signaling pathway,hsa04724:Glutamatergic synapse,hsa04726:Serotonergic synapse,hsa04730:Long-term depression,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04912:GnRH signaling pathway,hsa04913:Ovarian steroidogenesis,hsa04921:Oxytocin signaling pathway,hsa05231:Choline metabolism in cancer,			SM00022:PLAc,SM00239:C2,	Alternative splicing,Calcium,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Lysosome,Membrane,Metal-binding,Polymorphism,Reference proteome,Signal,	chain:Cytosolic phospholipase A2 zeta,domain:C2,domain:PLA2c,sequence conflict,sequence variant,splice variant,
PKP3	plakophilin 3(PKP3)	Homo sapiens				GO:0002159~desmosome assembly,GO:0016337~single organismal cell-cell adhesion,GO:0090002~establishment of protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0030057~desmosome,	GO:0045294~alpha-catenin binding,GO:0050839~cell adhesion molecule binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,				SM00185:ARM,	Alternative promoter usage,Cell adhesion,Cell junction,Complete proteome,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Plakophilin-3,modified residue,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,sequence conflict,
KCNS1	potassium voltage-gated channel modifier subfamily S member 1(KCNS1)	Homo sapiens				GO:0006813~potassium ion transport,GO:0051260~protein homooligomerization,GO:0071805~potassium ion transmembrane transport,GO:1902259~regulation of delayed rectifier potassium channel activity,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003971:Potassium channel, voltage dependent, Kv9,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,				SM00225:BTB,	Cell membrane,Complete proteome,Ion channel,Ion transport,Membrane,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily S member 1,compositionally biased region:Poly-Ala,region of interest:Segment H5 (pore-forming),sequence variant,short sequence motif:Selectivity filter,topological domain:Cytoplasmic,transmembrane region,
KCNJ13	potassium voltage-gated channel subfamily J member 13(KCNJ13)	Homo sapiens				GO:0006813~potassium ion transport,GO:0010107~potassium ion import,GO:0034765~regulation of ion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005242~inward rectifier potassium channel activity,	IPR008062:Potassium channel, inwardly rectifying, Kir7,IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic,IPR014756:Immunoglobulin E-set,IPR016449:Potassium channel, inwardly rectifying, Kir,	hsa04974:Protein digestion and absorption,	193230~Snowflake vitreoretinal degeneration,614186~Leber congenital amaurosis 16,	PIRSF005465:G protein-activated inward rectifier potassium channel,		Alternative splicing,Cataract,Complete proteome,Disease mutation,Ion channel,Ion transport,Leber congenital amaurosis,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Inward rectifier potassium channel 13,modified residue,region of interest:H5 (pore-forming helix),sequence variant,short sequence motif:Selectivity filter,site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
KCNJ5	potassium voltage-gated channel subfamily J member 5(KCNJ5)	Homo sapiens				GO:0006813~potassium ion transport,GO:0010107~potassium ion import,GO:0034765~regulation of ion transmembrane transport,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098914~membrane repolarization during atrial cardiac muscle cell action potential,GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential,GO:0099625~ventricular cardiac muscle cell membrane repolarization,GO:1990573~potassium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0030315~T-tubule,	GO:0005242~inward rectifier potassium channel activity,GO:0005515~protein binding,GO:0015467~G-protein activated inward rectifier potassium channel activity,GO:0086089~voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,GO:1902282~voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,	IPR003277:Potassium channel, inwardly rectifying, Kir3.4,IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic,IPR014756:Immunoglobulin E-set,IPR016449:Potassium channel, inwardly rectifying, Kir,	hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04726:Serotonergic synapse,hsa04728:Dopaminergic synapse,hsa04915:Estrogen signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05032:Morphine addiction,	613485~Long QT syndrome 13,613677~Hyperaldosteronism, familial, type III,	PIRSF005465:G protein-activated inward rectifier potassium channel,		Complete proteome,Disease mutation,Ion channel,Ion transport,Long QT syndrome,Membrane,Phosphoprotein,Polymorphism,Potassium,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:G protein-activated inward rectifier potassium channel 4,region of interest:H5 (pore-forming helix),sequence conflict,short sequence motif:Selectivity filter,site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PROM2	prominin 2(PROM2)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0031346~positive regulation of cell projection organization,GO:0043087~regulation of GTPase activity,GO:0048550~negative regulation of pinocytosis,GO:2000369~regulation of clathrin-mediated endocytosis,GO:2001287~negative regulation of caveolin-mediated endocytosis,	GO:0005887~integral component of plasma membrane,GO:0005902~microvillus,GO:0005929~cilium,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031528~microvillus membrane,GO:0042995~cell projection,GO:0044393~microspike,GO:0045121~membrane raft,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,GO:0071914~prominosome,	GO:0015485~cholesterol binding,	IPR008795:Prominin,					Alternative splicing,Cell membrane,Cell projection,Cilium,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Prominin-2,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PRSS3	protease, serine 3(PRSS3)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,GO:0009235~cobalamin metabolic process,GO:0031638~zymogen activation,GO:0043542~endothelial cell migration,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,hsa05164:Influenza A,			SM00020:Tryp_SPc,	3D-structure,Alternative splicing,Calcium,Complete proteome,Digestion,Disulfide bond,Hydrolase,Metal-binding,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,Sulfation,Zymogen,	active site:Charge relay system,chain:Trypsin-3,disulfide bond,domain:Peptidase S1,helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,modified residue,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,site:Required for specificity,splice variant,strand,turn,
PPP1R1A	protein phosphatase 1 regulatory inhibitor subunit 1A(PPP1R1A)	Homo sapiens				GO:0005977~glycogen metabolic process,GO:0006469~negative regulation of protein kinase activity,GO:0007165~signal transduction,GO:0035556~intracellular signal transduction,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004864~protein phosphatase inhibitor activity,GO:0004865~protein serine/threonine phosphatase inhibitor activity,GO:0005515~protein binding,	IPR008466:Protein phosphatase inhibitor, 1DARPP-32,	hsa04261:Adrenergic signaling in cardiomyocytes,hsa04720:Long-term potentiation,				Acetylation,Carbohydrate metabolism,Complete proteome,Direct protein sequencing,Glycogen metabolism,Phosphoprotein,Polymorphism,Protein phosphatase inhibitor,Proteomics identification,Reference proteome,	chain:Protein phosphatase 1 regulatory subunit 1A,modified residue,mutagenesis site,region of interest:Essential for activity,region of interest:Interaction with PPP1R15A,sequence conflict,sequence variant,
PTPRH	protein tyrosine phosphatase, receptor type H(PTPRH)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0006915~apoptotic process,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,	GO:0005001~transmembrane receptor protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR016130:Protein-tyrosine phosphatase, active site,				SM00060:FN3,SM00194:PTPc,SM00404:PTPc_motif,	Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protein phosphatase,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	active site:Phosphocysteine intermediate,chain:Receptor-type tyrosine-protein phosphatase H,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Tyrosine-protein phosphatase,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
REEP2	receptor accessory protein 2(REEP2)	Homo sapiens				GO:0032386~regulation of intracellular transport,GO:0032596~protein transport into membrane raft,GO:0050913~sensory perception of bitter taste,GO:0050916~sensory perception of sweet taste,GO:0071786~endoplasmic reticulum tubular network organization,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005881~cytoplasmic microtubule,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0031883~taste receptor binding,	IPR004345:TB2/DP1/HVA22-related protein,		615625~Spastic paraplegia 72, autosomal dominant,615625~Spastic paraplegia 72, autosomal recessive,			Alternative splicing,Complete proteome,Disease mutation,Hereditary spastic paraplegia,Membrane,Neurodegeneration,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Receptor expression-enhancing protein 2,splice variant,transmembrane region,
RDH8	retinol dehydrogenase 8 (all-trans)(RDH8)	Homo sapiens				GO:0006694~steroid biosynthetic process,GO:0006703~estrogen biosynthetic process,GO:0007601~visual perception,GO:0042572~retinol metabolic process,GO:0050896~response to stimulus,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005887~integral component of plasma membrane,	GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0004745~retinol dehydrogenase activity,GO:0052650~NADP-retinol dehydrogenase activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR011348:17beta-dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa00830:Retinol metabolism,hsa01100:Metabolic pathways,		PIRSF000095:estradiol 17beta-dehydrogenase,		Complete proteome,Membrane,NADP,Oxidoreductase,Polymorphism,Reference proteome,Sensory transduction,Signal,Transmembrane,Transmembrane helix,Vision,	active site:Proton acceptor,binding site:Substrate,chain:Retinol dehydrogenase 8,nucleotide phosphate-binding region:NADP,sequence variant,transmembrane region,
SLN	sarcolipin(SLN)	Homo sapiens				GO:0006816~calcium ion transport,GO:0043086~negative regulation of catalytic activity,GO:0043242~negative regulation of protein complex disassembly,GO:0051924~regulation of calcium ion transport,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0090281~negative regulation of calcium ion import,GO:1901020~negative regulation of calcium ion transmembrane transporter activity,GO:1901077~regulation of relaxation of muscle,GO:1901877~negative regulation of calcium ion binding,GO:1901881~positive regulation of protein depolymerization,GO:1901894~regulation of calcium-transporting ATPase activity,	GO:0016021~integral component of membrane,GO:0016529~sarcoplasmic reticulum,GO:0033017~sarcoplasmic reticulum membrane,	GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0030234~enzyme regulator activity,GO:0051117~ATPase binding,	IPR008028:Sarcolipin,					3D-structure,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Sarcoplasmic reticulum,Transmembrane,Transmembrane helix,	helix,peptide:Sarcolipin,strand,transmembrane region,
SFRP1	secreted frizzled related protein 1(SFRP1)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0001657~ureteric bud development,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006508~proteolysis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0009267~cellular response to starvation,GO:0009950~dorsal/ventral axis specification,GO:0010564~regulation of cell cycle process,GO:0010629~negative regulation of gene expression,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010975~regulation of neuron projection development,GO:0014034~neural crest cell fate commitment,GO:0014070~response to organic cyclic compound,GO:0022601~menstrual cycle phase,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030279~negative regulation of ossification,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0030336~negative regulation of cell migration,GO:0030514~negative regulation of BMP signaling pathway,GO:0033689~negative regulation of osteoblast proliferation,GO:0035019~somatic stem cell population maintenance,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043508~negative regulation of JUN kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0044345~stromal-epithelial cell signaling involved in prostate gland development,GO:0045578~negative regulation of B cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045765~regulation of angiogenesis,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046676~negative regulation of insulin secretion,GO:0046851~negative regulation of bone remodeling,GO:0048147~negative regulation of fibroblast proliferation,GO:0048546~digestive tract morphogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051496~positive regulation of stress fiber assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0060070~canonical Wnt signaling pathway,GO:0060218~hematopoietic stem cell differentiation,GO:0060346~bone trabecula formation,GO:0060527~prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,GO:0060687~regulation of branching involved in prostate gland morphogenesis,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0071305~cellular response to vitamin D,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071363~cellular response to growth factor stimulus,GO:0071380~cellular response to prostaglandin E stimulus,GO:0071391~cellular response to estrogen stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071456~cellular response to hypoxia,GO:0071481~cellular response to X-ray,GO:0071504~cellular response to heparin,GO:0071542~dopaminergic neuron differentiation,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071773~cellular response to BMP stimulus,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090179~planar cell polarity pathway involved in neural tube closure,GO:0090244~Wnt signaling pathway involved in somitogenesis,GO:0090246~convergent extension involved in somitogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1904956~regulation of midbrain dopaminergic neuron differentiation,GO:2000041~negative regulation of planar cell polarity pathway involved in axis elongation,GO:2000052~positive regulation of non-canonical Wnt signaling pathway,GO:2000054~negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,GO:2000080~negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,GO:2000270~negative regulation of fibroblast apoptotic process,GO:2000271~positive regulation of fibroblast apoptotic process,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0004930~G-protein coupled receptor activity,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0008144~drug binding,GO:0008201~heparin binding,GO:0017147~Wnt-protein binding,GO:0042802~identical protein binding,GO:0042813~Wnt-activated receptor activity,	IPR001134:Netrin domain,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR015526:Frizzled/secreted frizzled-related protein,IPR018933:Netrin module, non-TIMP type,IPR020067:Frizzled domain,IPR026559:Secreted frizzled-related protein 1,	hsa04310:Wnt signaling pathway,			SM00063:FRI,SM00643:C345C,	Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Secreted frizzled-related protein 1,disulfide bond,domain:FZ,domain:NTR,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,signal peptide,
SLPI	secretory leukocyte peptidase inhibitor(SLPI)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0006955~immune response,GO:0010951~negative regulation of endopeptidase activity,GO:0019731~antibacterial humoral response,GO:0032091~negative regulation of protein binding,GO:0032496~response to lipopolysaccharide,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,	GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0019899~enzyme binding,	IPR008197:Whey acidic protein-type  4-disulphide core,				SM00217:WAP,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Direct protein sequencing,Disulfide bond,Hydrolase,Immunity,Innate immunity,Protease,Protease inhibitor,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Antileukoproteinase,disulfide bond,domain:WAP 1,domain:WAP 2,region of interest:Elastase inhibitory domain,region of interest:Trypsin inhibitory domain,signal peptide,site:Reactive bond for chymotrypsin and elastase,site:Reactive bond for trypsin,strand,
SERPINC1	serpin family C member 1(SERPINC1)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway,		GO:0002438~acute inflammatory response to antigenic stimulus,GO:0007584~response to nutrient,GO:0007595~lactation,GO:0007596~blood coagulation,GO:0010951~negative regulation of endopeptidase activity,GO:2000266~regulation of blood coagulation, intrinsic pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0002020~protease binding,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008201~heparin binding,	IPR000215:Serpin family,IPR015555:Antithrombin-III,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,	hsa04610:Complement and coagulation cascades,	613118~Thrombophilia due to antithrombin III deficiency,		SM00093:SERPIN,	3D-structure,Blood coagulation,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemostasis,Heparin-binding,Phosphoprotein,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,Thrombophilia,	binding site:Heparin,chain:Antithrombin-III,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Reactive bond,strand,turn,
SAA1	serum amyloid A1(SAA1)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0006898~receptor-mediated endocytosis,GO:0006953~acute-phase response,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0030168~platelet activation,GO:0030593~neutrophil chemotaxis,GO:0044267~cellular protein metabolic process,GO:0045087~innate immune response,GO:0045785~positive regulation of cell adhesion,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050708~regulation of protein secretion,GO:0050715~positive regulation of cytokine secretion,GO:0050716~positive regulation of interleukin-1 secretion,GO:0050728~negative regulation of inflammatory response,GO:0050918~positive chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005881~cytoplasmic microtubule,GO:0034364~high-density lipoprotein particle,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,	GO:0001664~G-protein coupled receptor binding,GO:0008201~heparin binding,GO:0042056~chemoattractant activity,	IPR000096:Serum amyloid A protein,			PIRSF002472:amyloid protein, SAA type,	SM00197:SAA,	3D-structure,Acute phase,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,HDL,Heparin-binding,Methylation,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Amyloid protein A,chain:Serum amyloid A protein,chain:Serum amyloid protein A(2-102),chain:Serum amyloid protein A(2-103),chain:Serum amyloid protein A(2-104),chain:Serum amyloid protein A(3-104),chain:Serum amyloid protein A(4-101),modified residue,propeptide:Often cleaved during amyloidogenesis,sequence conflict,sequence variant,signal peptide,
SAA2	serum amyloid A2(SAA2)	Homo sapiens				GO:0006953~acute-phase response,GO:0050918~positive chemotaxis,GO:0060326~cell chemotaxis,	GO:0005615~extracellular space,GO:0034364~high-density lipoprotein particle,GO:0070062~extracellular exosome,	GO:0042056~chemoattractant activity,	IPR000096:Serum amyloid A protein,			PIRSF002472:amyloid protein, SAA type,	SM00197:SAA,	Acute phase,Alternative splicing,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,HDL,Polymorphism,Reference proteome,Secreted,Signal,	chain:Amyloid protein A,chain:Serum amyloid A protein,chain:Serum amyloid protein A(2-102),chain:Serum amyloid protein A(2-103),chain:Serum amyloid protein A(2-104),chain:Serum amyloid protein A(3-104),chain:Serum amyloid protein A(4-101),modified residue,propeptide:Often cleaved during amyloidogenesis,sequence conflict,sequence variant,signal peptide,
SAA4	serum amyloid A4, constitutive(SAA4)	Homo sapiens				GO:0006953~acute-phase response,GO:0050918~positive chemotaxis,GO:0060326~cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0034364~high-density lipoprotein particle,GO:0070062~extracellular exosome,	GO:0042056~chemoattractant activity,	IPR000096:Serum amyloid A protein,			PIRSF002472:amyloid protein, SAA type,	SM00197:SAA,	Acute phase,Complete proteome,Direct protein sequencing,Glycoprotein,HDL,Polymorphism,Reference proteome,Secreted,Signal,	chain:Serum amyloid A-4 protein,glycosylation site:N-linked (GlcNAc...); partial,sequence variant,signal peptide,
STAP1	signal transducing adaptor family member 1(STAP1)	Homo sapiens				GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009967~positive regulation of signal transduction,GO:0010628~positive regulation of gene expression,GO:0010760~negative regulation of macrophage chemotaxis,GO:0042326~negative regulation of phosphorylation,GO:0050861~positive regulation of B cell receptor signaling pathway,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0071222~cellular response to lipopolysaccharide,GO:1900028~negative regulation of ruffle assembly,GO:1902227~negative regulation of macrophage colony-stimulating factor signaling pathway,GO:1903980~positive regulation of microglial cell activation,GO:1903997~positive regulation of non-membrane spanning protein tyrosine kinase activity,GO:1904140~negative regulation of microglial cell migration,GO:1904151~positive regulation of microglial cell mediated cytotoxicity,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0043234~protein complex,	GO:0001784~phosphotyrosine binding,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005157~macrophage colony-stimulating factor receptor binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0019901~protein kinase binding,	IPR000980:SH2 domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00252:SH2,	3D-structure,Complete proteome,Cytoplasm,Mitochondrion,Nucleus,Phosphoprotein,Reference proteome,SH2 domain,	chain:Signal-transducing adaptor protein 1,domain:PH,domain:SH2,helix,modified residue,strand,
SMCO3	single-pass membrane protein with coiled-coil domains 3(SMCO3)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Coiled coil,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C12orf69,sequence variant,transmembrane region,
SMIM5	small integral membrane protein 5(SMIM5)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
SCN7A	sodium voltage-gated channel alpha subunit 7(SCN7A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006936~muscle contraction,GO:0019228~neuronal action potential,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0055078~sodium ion homeostasis,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0097386~glial cell projection,	GO:0005248~voltage-gated sodium channel activity,	IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04261:Adrenergic signaling in cardiomyocytes,				Cell membrane,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Sodium channel protein type 7 subunit alpha,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,transmembrane region,
SLC13A2	solute carrier family 13 member 2(SLC13A2)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0006810~transport,GO:0006814~sodium ion transport,GO:0006835~dicarboxylic acid transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0015361~low-affinity sodium:dicarboxylate symporter activity,	IPR001898:Sodium/sulphate symporter,					Alternative splicing,Complete proteome,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 13 member 2,sequence variant,transmembrane region,
SLC13A3	solute carrier family 13 member 3(SLC13A3)	Homo sapiens				GO:0006814~sodium ion transport,GO:0015746~citrate transport,GO:0055085~transmembrane transport,GO:0071422~succinate transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0015137~citrate transmembrane transporter activity,GO:0015141~succinate transmembrane transporter activity,GO:0015362~high-affinity sodium:dicarboxylate symporter activity,GO:0017153~sodium:dicarboxylate symporter activity,	IPR001898:Sodium/sulphate symporter,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Ion transport,Membrane,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 13 member 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,transmembrane region,
SLC2A12	solute carrier family 2 member 12(SLC2A12)	Homo sapiens				GO:0015992~proton transport,GO:0046323~glucose import,GO:1904659~glucose transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0012505~endomembrane system,GO:0048471~perinuclear region of cytoplasm,	GO:0005351~sugar:proton symporter activity,GO:0005355~glucose transmembrane transporter activity,GO:0055056~D-glucose transmembrane transporter activity,	IPR003663:Sugar/inositol transporter,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,					Complete proteome,Cytoplasm,Glycoprotein,Membrane,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 2, facilitated glucose transporter member 12,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC26A7	solute carrier family 26 member 7(SLC26A7)	Homo sapiens				GO:0001696~gastric acid secretion,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0008272~sulfate transport,GO:0015701~bicarbonate transport,GO:0019532~oxalate transport,GO:0042391~regulation of membrane potential,GO:0051453~regulation of intracellular pH,GO:1902358~sulfate transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0055038~recycling endosome membrane,	GO:0005254~chloride channel activity,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015301~anion:anion antiporter activity,GO:0019531~oxalate transmembrane transporter activity,	IPR001902:Sulphate anion transporter,IPR002645:STAS domain,IPR011547:Sulphate transporter,	hsa04971:Gastric acid secretion,				Alternative splicing,Anion exchange,Complete proteome,Endosome,Ion transport,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Anion exchange transporter,domain:STAS,region of interest:Membrane targeting,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC30A2	solute carrier family 30 member 2(SLC30A2)	Homo sapiens				GO:0010043~response to zinc ion,GO:0061090~positive regulation of sequestering of zinc ion,GO:0071577~zinc II ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,	GO:0005385~zinc ion transmembrane transporter activity,GO:0005515~protein binding,	IPR002524:Cation efflux protein,IPR027469:Cation efflux protein transmembrane domain,		608118~Zinc deficiency, transient neonatal,			Alternative splicing,Complete proteome,Disease mutation,Ion transport,Lysosome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,Vacuole,Zinc,Zinc transport,	chain:Zinc transporter 2,topological domain:Cytoplasmic,topological domain:Vacuolar,transmembrane region,
SLC34A2	solute carrier family 34 member 2(SLC34A2)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006817~phosphate ion transport,GO:0030643~cellular phosphate ion homeostasis,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0043627~response to estrogen,GO:0044267~cellular protein metabolic process,GO:0044341~sodium-dependent phosphate transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005903~brush border,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0031982~vesicle,	GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0005436~sodium:phosphate symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0042301~phosphate ion binding,	IPR003841:Sodium-dependent phosphate transport protein,		265100~Pulmonary alveolar microlithiasis,610441~Testicular microlithiasis,			Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transport protein 2B,compositionally biased region:Cys-rich,compositionally biased region:Poly-Thr,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC36A2	solute carrier family 36 member 2(SLC36A2)	Homo sapiens				GO:0006811~ion transport,GO:0006865~amino acid transport,GO:0015808~L-alanine transport,GO:0015816~glycine transport,GO:0015824~proline transport,GO:0035524~proline transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005280~hydrogen:amino acid symporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015180~L-alanine transmembrane transporter activity,GO:0015187~glycine transmembrane transporter activity,GO:0015193~L-proline transmembrane transporter activity,	IPR013057:Amino acid transporter, transmembrane,		138500~Hyperglycinuria,242600~Iminoglycinuria, digenic,			Alternative splicing,Amino-acid transport,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Proton-coupled amino acid transporter 2,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC4A11	solute carrier family 4 member 11(SLC4A11)	Homo sapiens				GO:0006814~sodium ion transport,GO:0015701~bicarbonate transport,GO:0015992~proton transport,GO:0030003~cellular cation homeostasis,GO:0035445~borate transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042044~fluid transport,GO:0046713~borate transport,GO:0051453~regulation of intracellular pH,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,	GO:0005272~sodium channel activity,GO:0005452~inorganic anion exchanger activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015252~hydrogen ion channel activity,GO:0015293~symporter activity,GO:0015301~anion:anion antiporter activity,GO:0046715~borate transmembrane transporter activity,GO:0046983~protein dimerization activity,	IPR002178:Phosphotransferase system, phosphoenolpyruvate-dependent sugar EIIA 2,IPR003020:Bicarbonate transporter, eukaryotic,IPR011531:Bicarbonate transporter, C-terminal,IPR016152:Phosphotransferase/anion transporter,		217400~Corneal endothelial dystrophy and perceptive deafness,217700~Corneal endothelial dystrophy 2, autosomal recessive,613268~Corneal dystrophy, Fuchs endothelial, 4,			Alternative splicing,Anion exchange,Cell membrane,Complete proteome,Corneal dystrophy,Deafness,Disease mutation,Glycoprotein,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium bicarbonate transporter-like protein 11,glycosylation site:N-linked (GlcNAc...),region of interest:Membrane (bicarbonate transporter),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC4A9	solute carrier family 4 member 9(SLC4A9)	Homo sapiens				GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0035725~sodium ion transmembrane transport,GO:0051453~regulation of intracellular pH,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0045177~apical part of cell,	GO:0005452~inorganic anion exchanger activity,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,GO:0015301~anion:anion antiporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,					Alternative splicing,Anion exchange,Antiport,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Anion exchange protein 4,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Membrane (anion exchange),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC52A1	solute carrier family 52 member 1(SLC52A1)	Homo sapiens				GO:0032218~riboflavin transport,GO:0046718~viral entry into host cell,	GO:0005887~integral component of plasma membrane,	GO:0001618~virus receptor activity,GO:0032217~riboflavin transporter activity,	IPR009357:Endogenous retrovirus receptor,		615026~Riboflavin deficiency,			Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Host cell receptor for virus entry,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Porcine endogenous retrovirus A receptor 2,compositionally biased region:Poly-Glu,sequence variant,signal peptide,transmembrane region,
SLC9A2	solute carrier family 9 member A2(SLC9A2)	Homo sapiens				GO:0006811~ion transport,GO:0008104~protein localization,GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR001953:Na+/H+ exchanger, isoform 2 (NHE2),IPR004709:Na+/H+ exchanger,IPR006153:Cation/H+ exchanger,IPR018422:Cation/H+ exchanger, CPA1 family,					Antiport,Complete proteome,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 2,glycosylation site:N-linked (GlcNAc...),region of interest:A (M1) hydrophobic,region of interest:B (M2) hydrophobic,region of interest:L, hydrophobic,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC9C2	solute carrier family 9 member C2 (putative)(SLC9C2)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0051453~regulation of intracellular pH,GO:0071805~potassium ion transmembrane transport,GO:0098719~sodium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0015299~solute:proton antiporter activity,GO:0015385~sodium:proton antiporter activity,GO:0015386~potassium:proton antiporter activity,	IPR000595:Cyclic nucleotide-binding domain,IPR006153:Cation/H+ exchanger,IPR014710:RmlC-like jelly roll fold,IPR018422:Cation/H+ exchanger, CPA1 family,IPR018490:Cyclic nucleotide-binding-like,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,					Antiport,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/hydrogen exchanger 11,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:cNMP,region of interest:Ion transport-like,sequence variant,transmembrane region,
SLCO1A2	solute carrier organic anion transporter family member 1A2(SLCO1A2)	Homo sapiens				GO:0006811~ion transport,GO:0008206~bile acid metabolic process,GO:0015711~organic anion transport,GO:0015721~bile acid and bile salt transport,GO:0043252~sodium-independent organic anion transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005215~transporter activity,GO:0008514~organic anion transmembrane transporter activity,GO:0015125~bile acid transmembrane transporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,	IPR002350:Kazal domain,IPR004156:Organic anion transporter polypeptide OATP,IPR020846:Major facilitator superfamily domain,	hsa04976:Bile secretion,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier organic anion transporter family member 1A2,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SSTR5	somatostatin receptor 5(SSTR5)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007268~chemical synaptic transmission,GO:0008285~negative regulation of cell proliferation,GO:0032467~positive regulation of cytokinesis,GO:0038170~somatostatin signaling pathway,GO:0042593~glucose homeostasis,GO:0050796~regulation of insulin secretion,GO:0071385~cellular response to glucocorticoid stimulus,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,	GO:0004994~somatostatin receptor activity,GO:0042923~neuropeptide binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000586:Somatostatin receptor family,IPR001184:Somatostatin receptor 5,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,	Somatostatin analog, resistance to~Somatostatin analog, resistance to,		SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Somatostatin receptor type 5,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SPTBN2	spectrin beta, non-erythrocytic 2(SPTBN2)	Homo sapiens				GO:0000165~MAPK cascade,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007010~cytoskeleton organization,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0016192~vesicle-mediated transport,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0021692~cerebellar Purkinje cell layer morphogenesis,GO:0030534~adult behavior,GO:0035264~multicellular organism growth,GO:0043547~positive regulation of GTPase activity,GO:0051693~actin filament capping,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0008091~spectrin,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0043025~neuronal cell body,	GO:0003779~actin binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005200~structural constituent of cytoskeleton,GO:0005543~phospholipid binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001605:Pleckstrin homology domain, spectrin-type,IPR001715:Calponin homology domain,IPR001849:Pleckstrin homology domain,IPR002017:Spectrin repeat,IPR011993:Pleckstrin homology-like domain,IPR016343:Spectrin, beta subunit,IPR018159:Spectrin/alpha-actinin,		600224~Spinocerebellar ataxia 5,615386~Spinocerebellar ataxia, autosomal recessive 14,	PIRSF002297:spectrin, beta subunit,	SM00033:CH,SM00150:SPEC,SM00233:PH,	3D-structure,Acetylation,Actin capping,Actin-binding,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Spinocerebellar ataxia,	chain:Spectrin beta chain, brain 2,domain:Actin-binding,domain:CH 1,domain:CH 2,domain:PH,helix,modified residue,repeat:Spectrin 1,repeat:Spectrin 10,repeat:Spectrin 11,repeat:Spectrin 12,repeat:Spectrin 13,repeat:Spectrin 14,repeat:Spectrin 15,repeat:Spectrin 16,repeat:Spectrin 17,repeat:Spectrin 2,repeat:Spectrin 3,repeat:Spectrin 4,repeat:Spectrin 5,repeat:Spectrin 6,repeat:Spectrin 7,repeat:Spectrin 8,repeat:Spectrin 9,sequence variant,splice variant,strand,turn,
SULT2B1	sulfotransferase family 2B member 1(SULT2B1)	Homo sapiens				GO:0000103~sulfate assimilation,GO:0008202~steroid metabolic process,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004027~alcohol sulfotransferase activity,GO:0005515~protein binding,GO:0050294~steroid sulfotransferase activity,	IPR000863:Sulfotransferase domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa00140:Steroid hormone biosynthesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,Lipid metabolism,Microsome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Steroid metabolism,Transferase,	active site:Proton acceptor,binding site:PAPS,chain:Sulfotransferase family cytosolic 2B member 1,compositionally biased region:Pro-rich,helix,mutagenesis site,nucleotide phosphate-binding region:PAPS,sequence conflict,sequence variant,splice variant,strand,turn,
SYN2	synapsin II(SYN2)	Homo sapiens				GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,	GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0043209~myelin sheath,GO:0045202~synapse,	GO:0003824~catalytic activity,GO:0005524~ATP binding,	IPR001359:Synapsin,IPR013815:ATP-grasp fold, subdomain 1,IPR013816:ATP-grasp fold, subdomain 2,IPR016185:Pre-ATP-grasp domain,IPR019735:Synapsin, conserved site,IPR019736:Synapsin, phosphorylation site,IPR020897:Synapsin, pre-ATP-grasp domain,IPR020898:Synapsin, ATP-binding domain,		181500~Schizophrenia, susceptibility to,			Alternative splicing,Cell junction,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,	chain:Synapsin-2,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,region of interest:A,region of interest:B; linker,region of interest:C; actin-binding and synaptic-vesicle binding,region of interest:E,region of interest:G; Pro-rich linker,region of interest:H; Pro/Ser-rich linker,sequence conflict,sequence variant,splice variant,
SYT3	synaptotagmin 3(SYT3)	Homo sapiens				GO:0006906~vesicle fusion,GO:0017156~calcium ion regulated exocytosis,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:1903861~positive regulation of dendrite extension,	GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0070382~exocytic vesicle,GO:0098793~presynapse,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,				SM00239:C2,	Calcium,Cell membrane,Complete proteome,Cytoplasmic vesicle,Differentiation,Disulfide bond,Membrane,Metal-binding,Methylation,Polymorphism,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-3,domain:C2 1,domain:C2 2,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SYT5	synaptotagmin 5(SYT5)	Homo sapiens				GO:0006906~vesicle fusion,GO:0007268~chemical synaptic transmission,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048488~synaptic vesicle endocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031045~dense core granule,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,GO:0055038~recycling endosome membrane,	GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,GO:0046982~protein heterodimerization activity,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,				SM00239:C2,	Alternative splicing,Calcium,Cell junction,Complete proteome,Cytoplasmic vesicle,Endosome,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Synapse,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-5,domain:C2 1,domain:C2 2,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 1; via carbonyl oxygen,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 2; via carbonyl oxygen,metal ion-binding site:Calcium 3,modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,
SYT7	synaptotagmin 7(SYT7)	Homo sapiens				GO:0001778~plasma membrane repair,GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0006909~phagocytosis,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0036465~synaptic vesicle recycling,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0046850~regulation of bone remodeling,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050764~regulation of phagocytosis,GO:0050796~regulation of insulin secretion,GO:0070092~regulation of glucagon secretion,GO:0090119~vesicle-mediated cholesterol transport,GO:0090385~phagosome-lysosome fusion,GO:1990926~short-term synaptic potentiation,GO:1990927~calcium ion regulated lysosome exocytosis,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030670~phagocytic vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031045~dense core granule,GO:0032009~early phagosome,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0070062~extracellular exosome,	GO:0001786~phosphatidylserine binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001565:Synaptotagmin,IPR015427:Synaptotagmin 7,				SM00239:C2,	3D-structure,Alternative splicing,Calcium,Calmodulin-binding,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Exocytosis,Lipoprotein,Lysosome,Membrane,Metal-binding,Palmitate,Peroxisome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Synapse,Transmembrane,Transmembrane helix,	chain:Synaptotagmin-17,chain:Synaptotagmin-7,compositionally biased region:Cys-rich,domain:C2 1,domain:C2 2,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,modified residue,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Vesicular,transmembrane region,turn,
TNS4	tensin 4(TNS4)	Homo sapiens				GO:0006915~apoptotic process,GO:0008104~protein localization,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR000980:SH2 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR013625:Tensin phosphotyrosine-binding domain,				SM00252:SH2,SM00462:PTB,	Actin-binding,Apoptosis,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,Signal,	chain:Tensin-4,compositionally biased region:Ser-rich,domain:Phosphatase tensin-type,domain:SH2,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,site:Cleavage; by caspase-3,
TF	transferrin(TF)	Homo sapiens	98.Dietary_Fat_and_Gene_Transcription,	h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport,		GO:0001895~retina homeostasis,GO:0002576~platelet degranulation,GO:0006879~cellular iron ion homeostasis,GO:0031647~regulation of protein stability,GO:0033572~transferrin transport,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0055072~iron ion homeostasis,GO:0071281~cellular response to iron ion,GO:0097460~ferrous iron import into cell,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005905~clathrin-coated pit,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030120~vesicle coat,GO:0030139~endocytic vesicle,GO:0031232~extrinsic component of external side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0034774~secretory granule lumen,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:0097433~dense body,GO:1990712~HFE-transferrin receptor complex,	GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0008199~ferric iron binding,GO:0015091~ferric iron transmembrane transporter activity,GO:1990459~transferrin receptor binding,	IPR001156:Transferrin family,IPR016357:Transferrin,IPR018195:Transferrin family, iron binding site,	hsa04066:HIF-1 signaling pathway,hsa04978:Mineral absorption,	209300~Atransferrinemia,	PIRSF002549:transferrin,PIRSF500682:serotransferrin  [Parent=PIRSF002549],	SM00094:TR_FER,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Ion transport,Iron,Iron transport,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transport,	binding site:Carbonate 1,binding site:Carbonate 1; via amide nitrogen,binding site:Carbonate 2,binding site:Carbonate 2; via amide nitrogen,chain:Serotransferrin,disulfide bond,domain:Transferrin-like 1,domain:Transferrin-like 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,modified residue,sequence conflict,sequence variant,signal peptide,strand,turn,
TMC3	transmembrane channel like 3(TMC3)	Homo sapiens				GO:0006811~ion transport,	GO:0016021~integral component of membrane,		IPR012496:TMC,					Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Transmembrane channel-like protein 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMPRSS2	transmembrane protease, serine 2(TMPRSS2)	Homo sapiens				GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0016540~protein autoprocessing,GO:0046598~positive regulation of viral entry into host cell,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001190:Speract/scavenger receptor,IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR017448:Speract/scavenger receptor-related,IPR018114:Peptidase S1, trypsin family, active site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa05164:Influenza A,hsa05202:Transcriptional misregulation in cancer,			SM00020:Tryp_SPc,SM00192:LDLa,SM00202:SR,	Alternative splicing,Autocatalytic cleavage,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal-anchor,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Transmembrane protease, serine 2 catalytic chain,chain:Transmembrane protease, serine 2 non- catalytic chain,disulfide bond,domain:LDL-receptor class A,domain:Peptidase S1,domain:SRCR,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
TMEM213	transmembrane protein 213(TMEM213)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 213,transmembrane region,
TMEM30B	transmembrane protein 30B(TMEM30B)	Homo sapiens				GO:0006869~lipid transport,GO:0070863~positive regulation of protein exit from endoplasmic reticulum,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR005045:Protein of unknown function DUF284, transmembrane eukaryotic,			PIRSF015840:Lem3/Cdc50,		Cell membrane,Complete proteome,Glycoprotein,Lipid transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Cell cycle control protein 50B,compositionally biased region:Poly-Asp,glycosylation site:N-linked (GlcNAc...),transmembrane region,
TRIM29	tripartite motif containing 29(TRIM29)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0098609~cell-cell adhesion,GO:1900181~negative regulation of protein localization to nucleus,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0045111~intermediate filament cytoskeleton,	GO:0002039~p53 binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000315:Zinc finger, B-box,				SM00336:BBOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 29,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:B box-type,
TRIM54	tripartite motif containing 54(TRIM54)	Homo sapiens				GO:0007017~microtubule-based process,GO:0007026~negative regulation of microtubule depolymerization,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0055001~muscle cell development,	GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0030018~Z disc,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017903:COS domain,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Metal-binding,Microtubule,Reference proteome,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 54,domain:COS,region of interest:Mediates microtubule-binding and homooligomerization,sequence conflict,splice variant,zinc finger region:B box-type,zinc finger region:RING-type,
TRIM63	tripartite motif containing 63(TRIM63)	Homo sapiens				GO:0006936~muscle contraction,GO:0007165~signal transduction,GO:0014732~skeletal muscle atrophy,GO:0014878~response to electrical stimulus involved in regulation of muscle adaptation,GO:0016567~protein ubiquitination,GO:0051384~response to glucocorticoid,GO:0070555~response to interleukin-1,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0030018~Z disc,GO:0031430~M band,	GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031432~titin binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017903:COS domain,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Muscle protein,Nucleus,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM63,domain:COS,helix,mutagenesis site,region of interest:Interaction with TTN,sequence variant,strand,turn,zinc finger region:B box-type,zinc finger region:RING-type,
TNNT1	troponin T1, slow skeletal type(TNNT1)	Homo sapiens				GO:0003009~skeletal muscle contraction,GO:0006937~regulation of muscle contraction,GO:0014883~transition between fast and slow fiber,GO:0030049~muscle filament sliding,GO:0031444~slow-twitch skeletal muscle fiber contraction,GO:0045932~negative regulation of muscle contraction,	GO:0005829~cytosol,GO:0005861~troponin complex,	GO:0005515~protein binding,GO:0005523~tropomyosin binding,GO:0031014~troponin T binding,	IPR001978:Troponin,		605355~Nemaline myopathy 5, Amish type,			Acetylation,Alternative splicing,Coiled coil,Complete proteome,Muscle protein,Nemaline myopathy,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Troponin T, slow skeletal muscle,modified residue,sequence conflict,splice variant,
TPSG1	tryptase gamma 1(TPSG1)	Homo sapiens				GO:0006508~proteolysis,	GO:0005887~integral component of plasma membrane,	GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Polymorphism,Protease,Reference proteome,Serine protease,Signal,Transmembrane,Transmembrane helix,Zymogen,	active site:Charge relay system,chain:Tryptase gamma,chain:Tryptase gamma heavy chain,chain:Tryptase gamma light chain,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,transmembrane region,
TSKU	tsukushi, small leucine rich proteoglycan(TSKU)	Homo sapiens				GO:0010468~regulation of gene expression,GO:0021540~corpus callosum morphogenesis,GO:0021670~lateral ventricle development,GO:0021960~anterior commissure morphogenesis,GO:0030178~negative regulation of Wnt signaling pathway,GO:0061073~ciliary body morphogenesis,	GO:0005615~extracellular space,		IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Complete proteome,Glycoprotein,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Tsukushin,glycosylation site:N-linked (GlcNAc...),repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,signal peptide,
TDRD5	tudor domain containing 5(TDRD5)	Homo sapiens				GO:0007286~spermatid development,GO:0030719~P granule organization,GO:0043046~DNA methylation involved in gamete generation,	GO:0033391~chromatoid body,GO:0071546~pi-body,		IPR002999:Tudor domain,IPR025605:OST-HTH/LOTUS domain,				SM00333:TUDOR,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Spermatogenesis,	chain:Tudor domain-containing protein 5,domain:Tudor,modified residue,sequence conflict,sequence variant,splice variant,
VNN2	vanin 2(VNN2)	Homo sapiens				GO:0006768~biotin metabolic process,GO:0006807~nitrogen compound metabolic process,GO:0006928~movement of cell or subcellular component,GO:0007417~central nervous system development,GO:0015939~pantothenate metabolic process,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,	GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0017159~pantetheine hydrolase activity,	IPR003010:Carbon-nitrogen hydrolase,IPR012101:Biotinidase, eukaryotic,	hsa00770:Pantothenate and CoA biosynthesis,		PIRSF011861:biotinidase, eukaryotic type,		Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:Vascular non-inflammatory molecule 2,compositionally biased region:Poly-Arg,domain:CN hydrolase,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,
VGLL1	vestigial like family member 1(VGLL1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0008022~protein C-terminus binding,	IPR006627:TDU repeat,IPR011520:Vestigial/tondu,				SM00711:TDU,	Complete proteome,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription cofactor vestigial-like protein 1,sequence variant,
VTN	vitronectin(VTN)	Homo sapiens				GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010951~negative regulation of endopeptidase activity,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030195~negative regulation of blood coagulation,GO:0030198~extracellular matrix organization,GO:0030449~regulation of complement activation,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0033627~cell adhesion mediated by integrin,GO:0035987~endodermal cell differentiation,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048709~oligodendrocyte differentiation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051258~protein polymerization,GO:0061302~smooth muscle cell-matrix adhesion,GO:0090303~positive regulation of wound healing,GO:0097421~liver regeneration,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0031012~extracellular matrix,GO:0048237~rough endoplasmic reticulum lumen,GO:0070062~extracellular exosome,GO:0071062~alphav-beta3 integrin-vitronectin complex,GO:0072562~blood microparticle,	GO:0005044~scavenger receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008201~heparin binding,GO:0030247~polysaccharide binding,GO:0042802~identical protein binding,GO:0050840~extracellular matrix binding,	IPR000585:Hemopexin-like domain,IPR001212:Somatomedin B domain,IPR018486:Hemopexin, conserved site,IPR018487:Hemopexin-like repeats,IPR020436:Somatomedin B, chordata,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05205:Proteoglycans in cancer,			SM00120:HX,SM00201:SO,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sulfation,	chain:Vitronectin,chain:Vitronectin V10 subunit,chain:Vitronectin V65 subunit,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,domain:SMB,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,peptide:Somatomedin-B,region of interest:Heparin-binding,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,site:Cleavage,strand,
VWA5B1	von Willebrand factor A domain containing 5B1(VWA5B1)	Homo sapiens					GO:0005576~extracellular region,		IPR002035:von Willebrand factor, type A,IPR013694:VIT domain,				SM00327:VWA,	Alternative splicing,Complete proteome,Glycoprotein,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:von Willebrand factor A domain-containing protein 5B1,domain:VIT,domain:VWFA,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
VWC2	von Willebrand factor C domain containing 2(VWC2)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,GO:0030514~negative regulation of BMP signaling pathway,GO:0045666~positive regulation of neuron differentiation,	GO:0005604~basement membrane,GO:0005614~interstitial matrix,GO:0005615~extracellular space,GO:0030054~cell junction,GO:0032281~AMPA glutamate receptor complex,GO:0045202~synapse,		IPR001007:von Willebrand factor, type C,				SM00214:VWC,	Basement membrane,Cell junction,Complete proteome,Extracellular matrix,Polymorphism,Reference proteome,Repeat,Secreted,Signal,Synapse,	chain:Brorin,compositionally biased region:Poly-Ala,domain:VWFC 1,domain:VWFC 2,sequence conflict,sequence variant,short sequence motif:Mediates cell adhesion,signal peptide,
XDH	xanthine dehydrogenase(XDH)	Homo sapiens		h_freePathway:Free Radical Induced Apoptosis,		GO:0001933~negative regulation of protein phosphorylation,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006195~purine nucleotide catabolic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007595~lactation,GO:0009115~xanthine catabolic process,GO:0010629~negative regulation of gene expression,GO:0045602~negative regulation of endothelial cell differentiation,GO:0051898~negative regulation of protein kinase B signaling,GO:0055114~oxidation-reduction process,GO:1900745~positive regulation of p38MAPK cascade,GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001213~negative regulation of vasculogenesis,	GO:0005615~extracellular space,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0016529~sarcoplasmic reticulum,	GO:0004854~xanthine dehydrogenase activity,GO:0004855~xanthine oxidase activity,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0016903~oxidoreductase activity, acting on the aldehyde or oxo group of donors,GO:0042803~protein homodimerization activity,GO:0043546~molybdopterin cofactor binding,GO:0050660~flavin adenine dinucleotide binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR000674:Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead,IPR001041:2Fe-2S ferredoxin-type domain,IPR002346:Molybdopterin dehydrogenase, FAD-binding,IPR002888:[2Fe-2S]-binding,IPR005107:CO dehydrogenase flavoprotein, C-terminal,IPR006058:2Fe-2S ferredoxin, iron-sulphur binding site,IPR008274:Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding,IPR012675:Beta-grasp domain,IPR014307:Xanthine dehydrogenase, small subunit,IPR016166:FAD-binding, type 2,IPR016167:FAD-binding, type 2, subdomain 1,IPR016169:CO dehydrogenase flavoprotein-like, FAD-binding, subdomain 2,IPR016208:Aldehyde oxidase/xanthine dehydrogenase,IPR022407:Oxidoreductase, molybdopterin binding site,	hsa00230:Purine metabolism,hsa00232:Caffeine metabolism,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways,hsa04146:Peroxisome,	278300~Xanthinuria, type I,	PIRSF000127:xanthine dehydrogenase,	SM01008:SM01008,SM01092:SM01092,	2Fe-2S,3D-structure,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,FAD,Flavoprotein,Glycoprotein,Iron,Iron-sulfur,Metal-binding,Molybdenum,NAD,Oxidoreductase,Peroxisome,Polymorphism,Reference proteome,Secreted,	active site:Proton acceptor,binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:Substrate,chain:Xanthine dehydrogenase/oxidase,disulfide bond,domain:2Fe-2S ferredoxin-type,domain:FAD-binding PCMH-type,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Iron-sulfur (2Fe-2S) 1,metal ion-binding site:Iron-sulfur (2Fe-2S) 2,metal ion-binding site:Molybdenum,metal ion-binding site:Molybdenum; via amide nitrogen,metal ion-binding site:Molybdenum; via carbonyl oxygen,modified residue,mutagenesis site,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,strand,turn,
ZNF114	zinc finger protein 114(ZNF114)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 114,domain:KRAB,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
